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ABSTRACT 
Amy E. Rydeen: Unnatural amino acid mutagenesis: Progress towards non-natural 
biocatalysis and investigations of protein thermodynamics via 19F NMR 
(Under the direction of Eric Brustad) 
Evolution created the complex and versatile protein landscape that underpins 
cellular function, through the combinatorial assembly of only 20 canonical amino 
acids. Contemporarily, protein engineers are expanding the capabilities of protein 
beyond the constraints of natural selection by tailoring them for applications in a 
‘man-made’ world. For instance, proteins are finding widespread success as 
immuno-therapeutics and as industrial catalysts for the production small molecule 
pharmaceuticals. However, the pursuit of protein engineers is hindered by the limited 
chemical functionality imparted by the natural proteinogenic amino acids. In vivo 
unnatural amino acid mutagenesis technology, also known as genetic code 
expansion, has allowed the localized and/or widespread installment of non-canonical 
amino acids bearing non-natural functional groups. This simple yet powerful 
technology has supplemented the fundamental few with hundreds of unnatural 
amino acids (UAAs). Despite the numerous applications of UAAs that have been 
disclosed, there still exists significant potential for further exploration. 
This dissertation advances the applications of UAA mutagenesis to include 
the installation of UAAs for novel biocatalysis and the biophysical investigation of 
protein and protein complex stability via 19F NMR. We present the design, synthesis 
and in vivo incorporation of organocatalyst-inspired proline-modified UAAs. Free 
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proline-elaborated UAAs perform aqueous aldol chemistry, however fail to transfer 
this activity to a protein scaffold. The groundwork discussed herein should assist 
future efforts towards the creation of protein catalysts with UAA-based reactivity. In 
addition, we utilized a 19F UAA to study the stability of a protein and weak protein 
complex in the presence of osmolytes and related biological small molecules via 19F 
NMR. The data demonstrate that although osmolytes are primarily characterized as 
protein stabilizing agents, related non-osmolytes stabilize a protein fold within the 
range of the most and least powerful osmolytes. On the other hand, osmolytes and 
non-osmolytes differ in their effect on the stability of a protein complex. Osmolytes 
had negligible influences on a charge mediated protein-protein interaction and non-
osmolytes were significantly perturbing. This result implies that osmolytes were 
selected by nature for their compatibility with the electrostatic interactions between 
protein surfaces that are attributed to the regulation of cellular function and structure.  
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PREFACE 
 At the time this thesis was composed, the final chapter, 19F NMR investigation 
of protein and protein complex stability via unnatural amino acid mutagenesis, was 
submitted as a research report to the Proceedings of the National Academy of 
Science (PNAS). The text of the chapter is verbatim as submitted, however the title 
was changed to reflect the narrative of this thesis.  The title of the submitted 
research report, was “Osmolytes are compatible with protein surfaces”.  
 Prior to submitting the thesis for publication, we received notification that the 
submission to PNAS was rejected. The final chapter has since been rewritten and 
submitted to the Journal of the American Chemical Society as a communication 
titled, Osmolytes and protein-protein interactions. 
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CHAPTER 1: IN VIVO UNNATURAL AMINO ACID MUTAGENESIS  
 
1.1 An introduction to genetic code expansion technology 
The in vivo incorporation of unnatural amino acids (UAAs) has proven to be 
an invaluable tool for the engineering of proteins and enzymes. UAAs can enhance 
protein stability, enzyme activity and selectivity, allow biophysical investigations of 
protein binding interactions, stability and dynamics, and create proteins with 
controlled and tunable photo- and chemical-reactive properties. Reviews of this 
technology, including its applications and the wealth of UAAs incorporated, continue 
to grow in size and number (1-8).  
The installation of UAAs in protein sequences has been approached in 
several ways in multiple organisms. Overall, two general approaches have emerged: 
residue-specific and site-specific incorporation of UAAs. Residue-specific 
incorporation replaces each location of a specific residue with a non-natural 
structural mimetic. For example, fluorinated isosteres of tryptophan and leucine and 
been readily incorporated into proteins proteome-wide, as their similar size and 
shape when compared to their native counterparts permits promiscuous use by the 
translational machinery. This technique has been used to increase thermostabilities 
of proteins by universal incorporation of fluorinated amino acid derivatives (9). 
Residue-specific incorporation is hindered, however, by its reliance on the 
permissiveness of endogenous tRNA synthetases, which restricts UAA scope to 
structural analogs of the 20 canonical amino acids. It also necessitates the 
 2 
deprivation of the canonical amino acid isostere from the growth media, which 
complicates and often contaminates scaled protein preparations. A major drawback 
to the residue specific method is the inability to select a single location for UAA 
incorporation. 
 The focus of this dissertation is the site-specific incorporation of UAAs via 
codon reassignment and suppression. This approach offers complete control over 
the location at which the UAA is installed and allows for multiple UAAs to be 
incorporated by reassigning multiple sense or non-sense codons. Herein, we employ 
Escherichia coli (E. coli) as a heterologous host for the engineering and production 
of proteins containing UAAs.  
 Site-specific incorporation of UAAs depends on the creation of orthogonal 
amino-acyl tRNA synthetase-tRNA (aaRS-tRNA) pairs unique for an UAA and 
reassigned codon. Orthogonality implies that the synthetase will not aminoacylate 
endogenous tRNAs and, in parallel, that the tRNA will not be recognized by native 
amino-acyl tRNA synthetases. The creation of orthogonal aaRS-tRNA pairs, in some 
cases, has proven to be straightforward since translational machinery from vastly 
different domains of life often do not cross-react with the E. coli translational 
apparatus. Two sets of aaRS-tRNA pairs have found widespread usage: the 
Methanococcua jannaschii tyrosyl-tRNA synthetase (MjTyrRS)-tRNA and the 
Methanosarcina mazei or Methanosarcina barkeri pyrrolysyl-tRNA synthetase (Mm 
or MbPylRS)-tRNA.  
 To genetically encode an unnatural amino acid, a codon that does not encode 
a canonical amino acid, typically the amber stop codon (TAG), is reassigned to 
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encode for the unnatural amino acid. This is accomplished first mutating the anti-
codon loop of the tRNA (tRNACUA); however, additional tRNA mutations are 
sometimes required to improve TAG-suppression efficiency. Next, the amino acid 
binding site of the synthetase is mutated and variants are screened or selected for 
the ability to specifically charge the tRNACUA with the unnatural amino acid of 
interest, Figure 1.1. Several positive and negative selection have been reported and 
have found wide spread application for the isolation of an orthogonal synthetase 
from often-large number, > 106, of generated mutant synthetases (7).  
 
Figure 1.1 Site-specific UAA incorporation 
(A) mutation and selection of an aaRS from different domain of life creates an orthogonal aaRS 
specific for the UAA. (B) UAG codons in mRNA encode for the UAA during translation on the 
ribosome.  
 
E. Coli
Mutation/selectionWT
aaRS
UAA
aaRS
A
Unnatural amino acid
Canonical amino acid
WT tRNA
UAG mRNA
UAA tRNA
B
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 Extensive mutational exploration of both MjTyRS and Mm- or MbPylRS has 
resulted in the creation of orthogonal aaRS-tRNA pairs specific for UAAs that span 
diverse structures and sizes, as shown in Figure 1.2. In summary, protein engineers, 
once limited by the diversity of the 20 canonical amino acids when making structural 
and chemical modifications to amino acid side chains, now have access to over 150 
unnatural amino acids containing diverse structures and non-natural chemical 
functional groups (2). Functional diversity of unnatural amino acids that have been 
site specifically genetically encoded include: (1) biophysical, spectroscopic and 
imaging probes, (2) handles for bio-orthogonal reactions, (3) post translation 
modifications (PTM) or PTM mimetics, and (4) photo-activated motifs such as photo-
caged, photo-isomerizable, or photo-crosslinkable amino acids. The reader is 
directed elsewhere for a review on the applications of this array of UAAs (10). 
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1110 12 13 14 15 16 17 18
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Figure 1.2 UAAs genetically encoded, in vivo, as of 2015 
The color of the number indicates the aaRS/tRNA pair used, orange is MjTyRS, blue is Mm or 
MbPylRS and green is other. Figure adapted from [Chem. Sci., 2015, 6, 50.]-Published by The Royal 
Society of Chemistr 
 
1.2 Selected applications of UAAs  
To underscore the functional utility of genetic code expansion methodology, 
select, but representative, applications of UAA mutagenesis are described below.  
1.2.1 UAAs install synthetic catalysts in protein scaffolds 
 Over billions of years, evolution has fine-tuned enzymes with catalytic 
capabilities near perfection. Enzymes demonstrate unrivaled selectivity, rate 
99 100 101 102 103 104 105 106 107
108 109 110 111 112 113 114 115 116 117 118
119 120 121 122 122 123 125 126 127 128
129 130 131 132 133 134 135 136 137 138
139 140 141 142 143 144 145 146 147
148 149 150 151 152 153 154 155 156 157 158
159 160 161 162 163 164 165 166 167
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enhancements and catalytic efficiencies for their native reactions (11, 12). 
Employing enzymes as compliments and/or supplements to conventional synthetic 
catalysts in industrial processes is a highly sought after goal. For example, enzymes 
operate under environmentally benign reaction conditions including in water at room 
temperature, neutral pH and without the need for organic solvents. However, it has 
proven challenging to engineer enzymes to catalyze industrial reactions on 
manmade substrates or to carry out chemical transformations that do not already 
occur in nature. The chemical capabilities of enzymes, resulting from the canonical 
20 amino acids and cofactors, are uniquely suited for and thereby limited by the 
natural world in which they evolved.  
 Genetic code expansion technology merges the chemical ingenuity and 
creativity of man with that exquisite and powerful translational machinery already 
developed by nature. Thus, the UAA mutagenesis provides a unique mechanism to 
expand enzyme chemical functionality beyond the constraints of nature’s design. For 
example, mounting conventional synthetic catalysts at a single site within protein 
active sites is possible through the use of UAAs displaying handles for covalent 
bioconjugation. Several classes of UAAs containing bio-orthogonal, or 
biocompatible, conjugation handles have been developed including reactive sites for 
Cu(I)-catalyzed or copper free alkyne-azide cycloaddtion (the so-called ‘click’ 
reaction), inverse-electron-demand Diels-Alder between tetrazines and strained 
alkenes, and the Staudinger ligation between alkyl azides and ester-functionalized 
triphenylphosphines, Figure 1.3 (13).  
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Figure 1.3 UAA-based bio-conjugation strategies 
(A) Select bio-orthogonal reactions for conjugation of catalysts to protein scaffolds. *Reactive 
functionality can be switched between catalytic moiety and UAA. For example, in the Cu(I)-free 
cycloaddition, a cyclooctyne UAA can be coupled with a catalytic moiety displaying an azide. Figure is 
adapted from Nat Chem Biol., 2013, 8, 475. (B) Select UAAs containing reactive bio-orthogonal 
handles. 
 
 UAA-based bioconjugation strategies, in particular, the strain-promoted azide-
alkyne cycloaddition (SPAAC, Figure 1.3A Cu(I)-free cycloaddition), have been 
exploited in the engineering of artificial metalloenzymes (ArMs) (14) . ArMs are 
hybrid catalysts composed of a covalently implanted conventional transition metal 
catalyst within the hydrophobic pocket of a protein scaffold. SPAAC between 
bicyclo[6.1.0]nonyne (BCN) and azide substituted reactive partners is a poplar 
conjugation strategy due to its rapid second order kinetics, bioorthogonality and 
specificity. Generally, an azide containing UAA is genetically encoded in a protein 
and subsequently reacted with a BCN-decorated transition metal catalyst. Because 
the conjugation will not proceed on naturally occurring amino acids, in theory, any 
protein could serve as a host, provided it can accommodate the UAA-catalyst pair. 
P
O
O
P
O
H
N
N3
Staudinger
ligation*
N N
N
N3
Cu(I)-catalyzed
cycloaddtion
N
N
N
N3
Cu(I)-free
Cycloaddtion
*
NN
N N H
H
H
N
NDiels-Alder 
cycloaddition*
Catalytic moiety
Incorporated UAA
H2N CO2H
HN
O
O
HH
H2N CO2H
HN
O
O
H2N CO2H
NH
N
NN
N
H2N CO2H
N N
NN
H2N CO2H
HN O
O
N3
H2N CO2H
N3
H2N CO2H
HN
O
O
H2N CO2H
HN O
O H
H
alkyne tetrazine
azide alkene
A B
 9 
 Highly stable proteins with large active sites, such as Pfu-POP, a member of 
the prolyl oligopeptidase (POP) family from Pyrococcus furiosus and tHisF, a 
synthase subunit of the glutaminase synthase from Thermatoga maritima have 
successfully hosted bulky BCN substituted synthetic metal catalysts (14, 15). Figure 
1.4 shows a schematic for the creation of an example ArM for cyclopropanation via 
bioconjugation of a BCN-substituted dirhodium catalyst with an azide UAA in the 
pocket of a scaffold protein.  
 
Figure 1.4 UAA-based SPAAC creates cyclopropanation ArM 
(A) A prolyl oligopeptidase from Pyrococcus furiosus displaying genetically encoded p-
azidophenylalanine within the active site is conjugated to bicyclo[6.1.0]nonyne substituted dirhodium 
complex and catalyzes the model cyclopropanation of styrene with donor-acceptor diazo compounds. 
(B) SPAAC bio-conjugation partners for the creation of an artificial metalloenzyme (ArM).   
 
 Primary ArM designs, constructed initially in a naïve protein scaffold by 
conjugation of the UAA and transition metal-catalyst, does not typically fabricate 
CO2Me
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catalysts with desirable yields or selectivities. Protein scaffolds often need to be 
engineered to complement and supplement the chemistry imparted by the catalyst.  
Rational mutagenesis of residues in proximity to the catalyst can enhance reactivity 
and/or selectivity but the methodology is time consuming and limited by the 
availability of a crystal structural for guidance (16). In addition, mutations outside of 
the active site can often contribute favorably to non-natural function, in unpredictable 
ways (17). However, mutations outside of the active site are difficult to predict, a 
priori, and require rigorous screening efforts to identify from random mutation 
libraries. 
 Directed evolution has been established as a key methodology for the non-
rational engineering of enzymes for non-natural catalysis (18). Directed evolution 
mimics natural selection through iterative rounds of mutagenesis and screening the 
mutant library for improvements in a desired characteristic. Recently, Lewis reported 
the first directed evolution of an ArM via non-rational mutagenesis (17). An ArM was 
constructed via SPAAC between a BCN substituted dirhodium catalyst and an azide 
displaying UAA in the active site of pfu POP. The enzyme was evolved through 
iterative rounds of error prone PCR and screening the library for improvements in 
the selectivity of cyclopropanation between alkene and diazo compounds. The 
resulting variant, obtained after 3 rounds of evolution contained 4 mutations, both 
within and beyond the active site, catalyzed the cyclopropanation with improved 
selectivity (92% e.e.) and yield (~75%) compared to the parent ArM.  
 To date, all attempts to engineer non-natural chemistry in proteins using 
genetic code expansion technology have sought to incorporate non-natural transition 
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metal centers into proteins. However, there are a number of alternative catalytic 
strategies, including organocatalysis and photoredox catalysis, that have yet to be 
explored in this expanding field of protein design. Chapter two of this thesis 
describes our progress at engineering novel UAA structures that will open novel 
organocatalytic motifs into biocatalysts. 
  
Figure 1.5 Directed evolution of bio-conjugation UAA-based ArM 
The scaffold protein, POP, is non-rationally mutated via error prone PCR to create a library of protein 
variants that are co-transformed with a plasmid harboring the orthogonal aaRS-tRNA pair specific for 
the UAA.  The scaffold variants are then expressed in the presence of UAA, lysed and clarified in a 
96 well format.  The ArM is constructed by addition of the catalyst equipped with the handle for bio-
conjugation to the UAA.  The resulting ArMs are screened for catalytic improvements, in this case, 
improved enantioselectivity in the cyclopropanation between styrene and diazo substrates. Hits are 
then verified on a large scale and subjected to further rounds of mutation and screening for further 
improvements. Figure adapted from Nature Chemistry, 2018,10, 318. 
 
1.2.2 Photocrosslinking UAAs investigate protein-protein interactions 
 Protein-protein interactions are universal and essential to the function of the 
cell. Mapping the cellular network of protein-protein interactions, which include both 
strong and weak contacts, furthers our understanding of disease (19). Traditional 
methods for studying these interactions, such as yeast 2-hybrid (Y2H) assays, are 
POP scaffold gene
library of mutant genes
colonies 
each 
carrying 
different 
mutant POP
screen mutants for 
improvements
random 
mutagenesis
co-transform with 
UAA incorporation 
plasmid
1. conjugate 
bio-
orthogonal 
catalyst
2. scavenge 
excess 
unreacted 
catalyst Time (min)
A
bs
or
ba
nc
e
isolate POP 
gene and 
repeat if 
insufficient
isolate, express 
and characterize 
sufficient hits on 
large scale
ArM library
scaffold library
CO2Me
N2
O
CO2Me
O
Directed Evolution
ArM library
1. express 
mutant 
POP in 96 
well format
2. lyse and 
clarify
additional 
rounds for 
further 
improvements
POP
 12 
performed under non-native conditions. Therefore, location specific and fleeting 
physiological interactions escape detection. Further, the Y2H methodology favors 
detection of strong interactions and many critical protein-protein interactions are 
weak and transient (20). Photocrosslinking UAAs offer many benefits over traditional 
non-covalent techniques of investigating the interaction of macromolecules in vivo 
and in vitro.  
 Photocrosslinking UAAs are activated by ultraviolet light to form radicals that 
undergo reaction with functional groups on a nearby associated proteins to 
covalently trap an otherwise weak interaction (3). Photocrosslinking UAAs detect 
specific protein-protein interactions and have minimal false identifications due to the 
high reactivity, short half-life and the ability of the activated state to relax or react 
with itself or water in the absence of a binding partner. The site-specific 
incorporation of three classes of photo-crosslinking UAAs, including 
benzophenones, aryl azides and alkyl and aryl diazarines has enabled the study of 
otherwise difficult to probe protein-protein interactions, such as membrane protein 
interactions (20-26).  
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Figure 1.6 Photocrosslinking UAAs and corresponding reactive radical species 
 
 The site-specific incorporation of p-benzoyl-L-phenylalanine (Bpa, UAA #5 
Figure 1.2) has found wide spread application in probing protein-protein interactions 
in Escherichia coli (21). The interaction between transmembrane protein complex, 
SecYEG, and SecA was elucidated, in vivo, using this UAA,  Figure 1.7 (27). The 
SecA – SecYEG interaction mediates post-translational translocation of outer 
membrane and periplasmic proteins across the inner membrane of E. coli. Bpa was 
site-specifically incorporated at 53 sites in the SecY protein of the SecYEG complex. 
This extensive scanning strategy identified previously unknown sites where SecA 
interacts with SecY in agreement with the crystal structure of the complex. Further, 
dynamics of the interaction were elucidated via in vivo experiments under stabilized 
conditions where the protein is locked in a ‘membrane inserted’ state and in vitro 
experiments where components (ATP, substrate, etc) were systematically omitted to 
probe how the interaction is dependent on the functional state of the both partners. 
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This example highlights the ability of site-specific UAA incorporation to study a 
difficult binding interaction under physiological conditions. 
 
 Figure 1.7 Bpa identifies residues of membrane protein-protein interaction 
The structure of SecA, blue, and SecY, orange, complex, PDB ID: 3DIN. The residues where Bpa 
was incorporated and in vivo crosslinking was observed are shown as yellow spheres.  
 Photocrosslinking UAAs are superior to non-covalent affinity based methods 
for the identification of weak, transient interactions. They provide structural 
information about distinct interfaces via site-specific interrogation of single residues 
in a protein-protein, protein-nucleic acid and/or protein-ligand interaction. Lastly, the 
identification of unknown biologically relevant interactions with minimal nonspecific 
linking facilitates the discovery and correct mapping of macromolecular interactions. 
1.2.3 UAAs as 19F NMR probes 
 Nuclear magnetic resonance (NMR) spectroscopy is a fundamental tool in the 
investigation of macromolecular structures, interactions, dynamics and 
thermodynamics. Proteins can be studied in vitro and in vivo at a global and 
SecA
SecY
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residue–specific level via NMR. Fluorine is an ideal nucleus for the visualization of 
protein by NMR. 19F is 100% naturally abundant, scarcely found in biology, 
hypersensitive to chemical environment when compared to 1H yet similar in size and 
therefore tolerated with minimal structural rearrangements (28). Labeling with 19F 
permits study of proteins otherwise too large for conventional 1H- and 15N-based 
NMR experiments. In addition, the spectra are significantly more simple to interpret 
(29). For these reasons, several UAAs containing fluorine have been developed and 
applied in the study of macromolecules via 19F NMR, see UAA # 34, 42, 46, and 47 
Figure 1.2. 
 The site-specific incorporation of 19F UAAs overcomes drawbacks of residue 
specific technology for producing 19F labeled proteins. Coaxing the native 
translational machinery to use fluorinated derivatives of natural amino acids, such as 
tryptophan, seldom reaches 95% incorporation at a single site and produces 
variability in labels throughout a protein sequence (30). The first report of the site-
specific incorporation of a fluorine containing UAA, trifluoromethyl-L-phenylalanine 
(TFMF, UAA # 42 Figure 1.2), detailed the in vivo production of large quantities of 
uniform, homogenous, singly 19F labeled protein (31). The UAA was incorporated at 
the interface active site of two dimeric proteins and reported structural changes of 
the complex resulting from inhibitor and substrate binding. Further, the signal of the 
labeled protein was sufficient to monitor chemical shift changes in cells given the 
UAA contains three equivalent 19F atoms.  
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Figure 1.8 TFMF at dimer interface reports structural changes via 19F NMR 
(A) Dimer shown with subunits colored orange and blue, PDB code: 1ICR. Site for TFMF are colored 
yellow, Phe 124 of the active site and Try36 at the interface.  Bound flavin mononucleotide, cofactor, 
is green and nicotinic acid, inhibitor, is pink. (B) Structure of TFMF.  
 
1.3 Furthering these applications of UAAs 
 This dissertation, rooted in the previously described applications of UAAs, 
furthers a novel yet underexplored application of UAA mutagenesis and expands 
upon established applications. Firstly, inspired by the UAA-based conjugation of 
synthetic catalyst in protein scaffolds, we report progress towards the direct 
installation of catalytic moieties via the in vivo incorporation of catalytic UAAs 
employing orthogonal aaRS-tRNA pairs. We then discuss an 19F NMR biophysical 
investigation of protein and protein complex stability utilizing the UAA, 
trifluoromethyl-L-phenylalanine (TFMF).  
1.3.1 UAAs as synthetic catalysts in protein scaffolds 
The genetic incorporation of catalytic unnatural amino acids as a mean to 
introduce non-natural chemistry to protein scaffolds represents an untapped 
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application of genetic code expansion technology. There is only one instance of in 
vivo unnatural amino acid incorporation for direct enantioselective catalysis (32). A 
metal binding amino acid, (2,2’-bipyridin-5yl) alanine (BpyAla), was installed in the 
hydrophobic cavity of the dimer interface of Lactoccocal multidrug resistance 
regulator (LmrR). The protein harboring the unnatural amino acid bound to copper(II) 
was able to catalyze a Friedel-Crafts acylation of 2-methylindole with 22% 
conversion and 66% enantiomeric excess after optimization of location of the UAA 
and mutation to residues proximal the Cu(II) catalyst, Figure 1.9.  
 
Figure 1.9 In vivo incorporation of metal binding UAA for catalysis 
Friedel-Crafts acylation of indoles by ArM created by genetically encoding BpyAla at the dimer 
interface of LmrR. Enantioselectivity was improved by rational mutagenesis of residues proximal to 
BpyAla.  
 
 In contrast to the singular report of a UAA acting as the catalytic moiety of 
protein catalyst, UAAs are frequently used to tether conventional catalysts in the 
hydrophobic pocket of protein scaffolds (33). Although this strategy has successfully 
fashioned ArMs for enantiocatalysis, it represents a significant engineering effort. 
We suggest that engineering non-natural protein catalysts via in vivo incorporation of 
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catalytic amino acids offers advantages over UAA- or canonical amino acid-based 
conjugation strategies. The most prominent benefit would be the direct simplification 
of the catalyst production methodology, Figure 1.10. When utilizing a catalytic UAA, 
the active protein scaffold is purified from a heterologous host and characterized in a 
single event. In contrast, for unnatural amino acid-based bio-conjugation of a 
catalyst, the protein scaffold must be purified from the expression host, conjugated 
to a catalyst and subsequently re-purified from non-conjugated catalyst. 
Consequently, iterative optimization, i.e. directed evolution, of the hybrid protein-
catalyst conjugate is challenging and only one instance has been reported (17). 
Directed evolution, consisting of random mutagenesis followed by high throughput 
screening of the mutant library necessitated the removal of excess non-conjugated 
catalyst prior to screening to avoid skewing of yields and selectivities, Figure 1.5.  
  Selection of a protein scaffold to host the catalyst is a complicated endeavor 
of concern to both direct-UAA and bioconjugation-UAA based strategies for catalyst 
immobilization. In both cases, the scaffold should be highly stable in order to tolerate 
extensive mutations for engineering and optimization, and to facilitate high 
throughput purification. However, we highlight that catalytic UAAs may expand the 
viable scaffold structures because they can be designed in a more compact fashion 
(i.e. no linkers and bioconjugation handles are necessary) and introduced into 
proteins directly (not through post-translational bioconjugation). For example, only a 
select few scaffolds have been proven capable of accommodating bulky BCN-
containing UAAs, #99 and 103 in Figure 1.2, which are necessary for the favored 
SPAAC conjugation strategy. Therefore, the UAA-based bioconjugation of catalysts 
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places challenging steric constraints on the proteins’ hydrophobic core. Catalytic 
UAA’s negate the inclusion of bio-conjugation handles that often contribute to the 
steric bulk of the conjugated catalyst. Catalytic UAAs may also alleviate the 
complexity and laborious nature of synthesizing both bio-conjugation partners, the 
UAA and the catalyst.   
 
Figure 1.10 Advantage of installation of UAA-based catalyst 
 
 In vivo incorporation of catalytic UAAs may prove more attractive than 
alternative strategies for the creation of non-natural protein catalysts, including 
cysteine conjugation of catalysts and recruitment of cofactor-based catalysts in a 
protein scaffold. ArMs have been created via the introduction of a single cysteine 
residue and subsequent nucleophilic attack of the residue on a reactive site on a 
conventional catalyst (34). This strategy can require labor intensive mutational 
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efforts if many cysteines must be removed from the native protein scaffold (35). In 
contrast, UAA-based catalysts only require a single TAG mutation to site-selectively 
install the catalyst. Another popular strategy for the construction of ArM is the 
recruitment of cofactor-like catalysts to protein hydrophobic cores. For example, 
synthesizing a biotin containing catalytic complex and sequestering it within the 
streptavidin cavity has created ArM with novel non-natural catalytic functionality (36). 
However, this strategy suffers from the same labor intensive methodology as does 
the UAA-based bio-conjugation of catalysts within protein hosts. In addition, it is 
specific to the mutational and spatial restrictions of the streptavidin pocket. UAA-
based installment of catalytic moieties would be possible in any given protein 
scaffold with the introduction a single TAG codon mutation. 
1.3.2 Quantifying protein complex stability via 19F NMR UAA probes 
 Non-natural chemical functionality contributed by UAAs has furthered the 
study of protein-protein interactions. Specifically, light activated photocrosslinking 
UAAs have been extensively exploited to probe protein interfaces in a site-specific 
manner (27). This technology has accelerated the identification of weak protein-
protein interactions under physiological conditions (20). However, by nature of the 
covalent, irreversible, entrapment of protein binding partners, equilibrium 
thermodynamic quantification of the interaction is not possible. Therefore, other 
strategies must be undertaken to determine how manipulation of the environment 
under which the interaction occurs effects the stability of the complex.  
 In the final chapter in this dissertation, we employ a 19F-containing UAA, 
TFMF, to quantity the stability of a weak protein-protein interaction and a protein 
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under various conditions. This project adds to the small subset of 19F NMR protein 
investigations that utilize the site specific in vivo incorporation of unnatural amino 
acids (30, 31, 37-40). To date, the favored method to install 19F probes is the residue 
specific manner exploiting native translational machinery (29, 41-43). However, 
replacing all locations of a residue (typically tryptophan or tyrosine) with fluorinated 
derivatives can destabilize the protein structure and complicate assigning 
resonances, especially for large proteins with many labeling sites. These 
impediments can limit ideal proteins for investigation to those with single sites for 
fluorine labeling and those that tolerate structural perturbations. In addition, protein 
expression must be done under deprived conditions or in auxotrophic strains to 
reduce canonical amino acid incorporation. Utilizing of the site-specific incorporation 
of UAAs provides a singly labeled protein expressed in rich media in standard 
heterologous hosts.   
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CHAPTER 2: GENETICALLY ENCODING ORGANO-CATALYTIC UNNATURAL 
AMINO ACIDS 
 
2.1 Introduction 
In nature, enzymes catalyze the synthesis of complex, enantiopure 
compounds with impressive rate enhancements (kcat/knon), highlighted by the highest 
observed kcat/knon reaching ~ 1021 (44). Moreover, enzymes operate under mild 
conditions, i.e. in water at physiological temperature, pressure and pH. 
Consequently, enzymes are increasingly being applied to the production of 
agrochemicals, pharmaceuticals, and fine and bulk chemical commodities (45). 
While enzymes are attractive alternatives and/or complements to synthetic catalysts, 
they are inherently limited by their chemical composition. This restricts the synthetic 
applications of enzymes to chemical transformations observed in nature. Expanding 
the catalytic behavior of enzymes beyond the ability of the canonical amino acids, 
native cofactors and bioavailable substrates is a contemporary goal.   
 Several tools for installing non-natural activity into enzymes have emerged. 
These include incorporating transition metals or metal complexes into proteins (46), 
de novo design using computational methods (47) and exploitation of enzyme’s 
inherent promiscuity (that is, the ability of an active site to carry out a mechanistically 
similar reaction to its native chemistry) (48). Introducing non-natural transition metal 
based chemistry into enzymatic scaffolds represents one of the earliest and most 
prolific fields of biocatalyst engineering (49)
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sphere provided by the biomolecular scaffold can be tuned to enhance the selectivity 
and activity of the metal-based chemistry. However, transition metals often require 
unfavorable reaction conditions such as the need for degassed buffer, absence of 
light and inert atmospheres (50-52). The de novo design of proteins with non-natural 
capabilities is appealing but computational efforts, to date, have yielded catalyst with 
catalytic efficiencies that are orders of magnitude lower than native enzymes (53). 
These activities may reflect current limitations in computational methods, which are 
unable to account for long-range, cooperative interactions and the complex and 
dynamic nature of protein fluctuations (47). Frances Arnold and colleagues engineer 
non-natural enzymatic catalysts by exploiting the promiscuity of metal cofactors in 
natural enzymes. Heme-enzymes including cytochrome P450s, cytochrome C and 
globins, have all been evolved to catalyze diverse reactions including, olefin 
cyclopropanation, C-H amination, sulfimidation and N-H insertions through 
mechanistic intermediates similar to the active oxidant of cytochrome P450 (54, 55). 
However, this strategy is limited to reactions that are mechanistically similar to 
existing enzyme catalysis.  
 Genetic code expansion beyond the canonical 20 amino acids using 
orthogonal aminoacyl-tRNA synthetase-tRNA (aaRS-tRNA) pairs represents an 
attractive method to install non-natural reactivity (4). This method is particularly 
compelling since unnatural amino acids (UAAs) can be incorporated into proteins via 
the native translational machinery, obviating the need for extensive post-translational 
manipulation of the protein of interest. In addition, >150 novel amino acid structures 
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have been incorporated into proteins via this approach, Figure 1.2, attesting to the 
diverse chemical structure that can be translated by the ribosome (2).  
 While the chemical functionality made available by UAA technology continues 
to grow, its applications for enantioselective catalysis remain confined to a select few 
approaches. With respect to biocatalysis, the use of UAAs has been markedly 
under-investigated. UAAs have predominately been employed as biorthogonal 
chemical handles for the covalent attachment of metal-based catalysts within a 
protein scaffold. This approach has created novel iron proteins that carry out the 
Fenton reaction (56) and Rh2 catalysts competent for non-natural carbenoid 
insertion reactions including cyclopropanation of olefins (33). However, bulky 
conjugation handles place steric constraints on the choice of scaffold, limiting 
options. In addition, the methodology necessitates synthesis of both catalyst and 
UAA equipped with conjugation partners. Lastly, the protein must be purified and 
characterized from the heterologous host, followed by conjugation and subsequent 
purification and characterization.  
We propose the creation of proteins capable of non-natural catalysis through 
the in vivo incorporation of catalytic unnatural amino acids. This represents an 
untapped application of the genetic code expansion technology. To date, there is 
only one report of in vivo incorporated UAA-based enantioselective catalysis. 
Located in the hydrophobic cavity of a protein dimer interface, the metal binding 
amino acid, BpyAla, bound to copper (II) catalyzed the Friedel-Crafts acylation, 
although with poor conversion (22%) and modest selectivity (66% e.e.), Figure 1.9 
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(32). Although modular exploration of chiral and steric aspects of the surrounding 
protein scaffold enhanced the UAA-based activity.  
 The majority of non-natural enzyme catalysis centers on transition metal-
based chemistries. Herein, we draw inspiration from the marriage of metallo- and 
biocatalysis and seek to unite bio- and organocatalysis. Since the year 2000, 
organocatalysis, the use of small organic molecules to catalyze reactions has 
exploded in the synthetic community. Sparked by two back-to-back publications by 
Barbas and MacMilllan, the field of organocatalysis has grown rapidly (57, 58). 
Organocatalysts are typically cheap, available in enantiopure forms, operate under 
mild conditions and are less toxic than metal catalysts (59). Through the work of 
groups such as MacMillan, Barbas, Corey, JØrgensen and List, organocatalysis has 
been established as an invaluable tool, complementary to transition metal based 
approaches, for the enantioselective construction of molecules (59-67).   
 Therefore, we propose the site-specific in vivo incorporation of 
organocatalytic amino acids into protein scaffolds for the evolution of novel enzymes 
with the potential for stereo-selective catalysis. Enzymatic active sites provide an 
environment for engineered selectivity and activity while, in a complementary 
fashion, the organocatalyst motif should foster broadly applicable modes of action 
for various chemical transformations in a manner that is dependent on the UAA side 
chain. 
  Among organocatalysts, secondary amines are perhaps the most widely 
utilized for enantioselective synthesis (68, 69). The versatility of secondary amine 
catalysis stems from the capability and complementary of two activation modes, 
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enamine and iminium ion formation, Figure 2.1. This dual activation can be used for 
nucleophilic (enamine) or electrophilic (iminium ion) activation of carbonyl containing 
compounds.  
 
Figure 2.1 Enamine and iminium ion catalysis by secondary amines 
(A) enamine mode of activation and potential nucleophilic reactions. (B) Iminium ion activation mode 
and potential electrophilic transformations.  
 
 Representative of this chemistry, the amino acid proline has served as a 
model and highly utilized secondary amine organocatalyst, Figure 2.2. Since the 
initial documentation of the proline catalyzed intermolecular aldol reaction, proline 
has been applied to many enamine-type reactions (57). In addition, proline has been 
utilized as a Lewis acid catalyst through iminium ion formation and employed in 
various cycloadditions as well as conjugate addition reactions functionalizing α, β 
unsaturated compounds. Furthermore, cyclopropanation and epoxidation are 
possible under a tandem mechanism in which the enamine formed after addition to 
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the iminium ion is trapped by an electrophilic species (68, 69). We hypothesize that 
the genetic incorporation of proline containing amino acids will enable the 
construction of evolvable protein catalysts for enantioselective enamine/iminium ion 
based via mechanisms that are comparable and complementary to reactions 
catalyzed by simple small molecule proline derivatives.   
 
Figure 2.2 Versatility of proline as enamine and iminium ion organocatalyst 
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2.2  Results and discussion 
2.2.1 Unnatural amino acid design and synthesis 
We began our efforts with the design and synthesis of two unnatural amino 
acids equipped with a proline moiety. The structures of the amino acid were 
designed to target both sets of commonly used orthogonal aaRS/tRNA pairs: the 
Methanococcua jannaschii tyrosyl-tRNA synthetase (MjTyrRS)-tRNA and the 
pyrrolysyl-tRNA synthetase (PylRS)-tRNA from Methanosarcina barkeri, by creating 
a tyrosine and pyrrolysine based unnatural amino acid.  
For the orthogonal MjTryRS-tRNA pair, many of the first reports of UAA 
incorporation centered on para-substituted phenyl ring derivatives for use in 
bioconjugation (24, 70-73). In addition, bulky para-substituents such as tetrazine 
(74), tetrazole (75), and benzophenone (21) groups and conjugated aromatic 
systems such as 2-naphthol (76) have been incorporated by engineered MjTyRS 
variants. Inspired by the successful engineering of MjTyRS for the in vivo 
incorporation of diverse para-substituted UAAs, we designed proline-4-amino-L-
phenylalanine (Pro4AF). The UAA provides a rigid scaffold to display the active 
proline moiety which may prove beneficial for enantioselective catalysis in addition to 
the potential for π interactions with substrates or active site side chains.  
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Figure 2.3 Substrates of engineered MjTyRS 
(A) The native substrate of MjTyRS. (B) The proline containing tyrosine derived UAA utilized in this 
study. (C) Diverse UAAs in vivo incorporated by the orthogonal MjTyRS/tRNA pair.  
 
Codon reassignment in E.coli utilizing the orthogonal aaRS/tRNA machinery 
pyrrolysine (the so-called 22nd canonical amino acid), has been very successful due 
to the remarkably flexible substrate scope demonstrated by the wild type pyrrolysyl 
tRNA synthetase (PylRS) and its variants. The earliest investigation into the 
structural requirements for PylRS substrate recognition identified several proficient 
substrate analogs (2, 5, 6 in Figure 2.4) (77) followed by numerous and growing 
reports of the diverse chemical structures accommodated by PylRS and its variants, 
see Figure 1.2. Related to our efforts, this study reported the incorporation of a 
proline-modified pyrrolysine analog, D-prolyl-L-lysine (ProK), albeit with poor 
efficiency (77). Based on the known flexibility of PylRS, we also chose ProK as a 
starting point for our efforts.  
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Figure 2.4 Substrates of the wild type pyrrolysine synthetase (WT-PylRS) 
(A) The 22nd amino acid, pyrrolysine. (B) UAAs utilized in this study: ProK, the proline containing UAA 
and BocK, a positive control for WT-PylRS. (C) Diverse UAAs recognized by WT-PylRS that are 
structurally and chemical similar to proK. 
 
 The synthesis of Pro4AF and ProK are described in detail in Small molecule 
synthesis and characterization 2.5.3. Briefly, to construct Pro4AF, a 9-BBN 
protecting group strategy was employed followed by routine amine to amide 
dicylcohexylcarboiimide coupling. The 9-BBN protection of 4-amino-L-phenylalanine 
and subsequent coupling to Boc-D-proline proceeded in an overall 53% yield. The 
synthesis of ProK was modified from original reports in which yields were not 
conducive to scaled preparation. Our synthetic strategy first activated Boc-D-proline 
as a N-hydroxysuccinimide carbonate followed by coupling to N-a-Boc-protected L-
lysine followed by dual deprotection. The three-step synthesis was carried out in an 
overall yield of 64%. Unnatural amino acid synthesis was verified by mass 
spectrometry and 1H NMR analysis, see 2.5.41H NMR .  
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Figure 2.5 Proline-containing UAAs: Pro4F and ProK 
 
2.2.2 The search for a Pro4AF synthetase  
Initial efforts focused on the in vivo incorporation of Pro4AF. This work 
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well as small polar substituents. Our screen also included alanine mutations at 
amino acid positions N246 and C248 in the MbPylRS system, which have been 
shown to induce broad tolerance to phenylalanine derivatives, including bulky para-
substituted derivatives (78), in PylRS. The complete list of synthetases evaluated is 
given in Table 2.1.  
We utilized a green fluorescent protein (GFP) construct with a TAG codon at 
position 149 to screen potential tRNA synthetases. The detailed procedure is 
described in the methods (“GFP-based synthetase screen for Pro4AF 
incorporation”). Briefly, each individual tRNA synthetases was co-transformed with a 
GFP-149TAG construct. Expression was then carried out in the presence of Pro4AF.  
If the TAG codon was suppressed with the UAA, full length GFP would be produced 
and the extent of expression was qualitatively determined by fluorescence intensity 
of clarified lysates. Expression was simultaneously carried out in the absence of 
Pro4AF to judge the level of expression resulting from TAG suppression with 
canonical amino acids. Synthetases were deemed successful if fluorescence 
intensity was greater in the presence of Pro4AF than in the absence. Unfortunately, 
no synthetase was identified that met this qualification. As an alternative, it may be 
possible to construct and assess large, but non-trivial, libraries of MjTyrRS variants 
for ProAF incorporation. However, with a second amino acid in hand and based on 
the known, broadened substrate specificity of PylRS, we chose to instead direct our 
efforts toward ProK incorporation. Further evolution of MjTyrRS for ProAF remains a 
possible future target for this research. 
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Table 2.1 Aminoacyl-tRNA synthetases evaluated for Pro4AF incorporation 
MjTyrRS variants MbPylRS variants 
p-acetyl-phenylalanine pyrrolysine 
p-azido-phenylalanine pyrrolysine L274A C313A Y349F 
p-benzoylphenylalanine pyrrolysine L274A C313S Y349F 
p-(2,2'-bipyridin-5-yl)alanine pyrrolysine C313A Y349F 
p-boronophenylalanine pyrrolysine C313S Y349F 
p-cyano-phenylalanine pyrrolysine Y349F 
p-carboxylmethyl-phenyalanine pyrrolysine 246A 248A 
p-(7-hydroxycoumarin-4-yl) ethylglycine pyrrolysine 246A 248L 
p-(8-hydroxy-quinolin-3-yl)alanine pyrrolysine 246V 248W 
p-iodo-phenylalanine pyrrolysine 246S 248W 
p-isopropyl-phenylalanine pyrrolysine 246T 248T 
p-hydroxy-L-phenyllactic acid pyrrolysine HRS 
p-proparglyoxyphenylalanine  
p-nitrophenylalnine  
3-(2-naphthyl)alanine  
o-nitrobenzyl-tyrosine  
sulfotyrosine  
o-methyl-tyrosine  
p-amino-phenylalanine  
tyrosine  
 
2.2.3 MbPylRS accepts ProK  
 In light of unsuccessful attempts to incorporate a tyrosine-based proline UAA, 
in vivo, we turned our attention to the pyrrolysine based UAA, ProK. This UAA has 
been previously identified as a substrate analogue of the pyrrolysyl-tRNA synthetase 
from Methanosarcina barkeri (MbPylRS), albeit with a reported 18% suppression 
efficiency (77). This observation was qualitatively verified in our hands using the 
GFP-based fluorescence reporting system. Herein, we report fluorescence intensity 
with respect to 1 mM BocK (an efficient substrate of MbPylRS known to be 
incorporated at high yields and a standard positive control in our lab). Fluorescence 
intensity of clarified cellular lysate after expression of GFP-TAG in the presence of 2 
mM ProK was found to be 9-fold less than in the presence of 1 mM BocK but seven 
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times greater than in the absence of ProK. A 2-fold improvement was observed with 
the addition of 5 mM ProK to the media, Figure 2.6, however further increases in 
amino acid concentration did not provided additional improvements in incorporation. 
GFP obtained from expressions in the presence of ProK was purified from cellular 
lysate and subjected to analysis via mass spectrometry, which revealed the 
successful incorporation of intact ProK at position 149 (Figure 2.6, expected mass, 
m/z = 27938.6, observed mass m/z = 27938.6).  
 
Figure 2.6 Incorporation of ProK into GFP by MbPylRS 
(A) GFP fluorescence intensity of clarified lysate after expression in the absence, negative control, 
and presence of UAAs.  (B,C) Mass spectrometry analysis of GFP149ProK, expected mass, m/z = 
27938.6, observed mass m/z = 27938.6. Truncation corresponding to cleavage of starting methionine 
residue is observed.  
 
2.2.4 Free ProK aldol catalysis  
After verification of incorporation of ProK into a protein sequence in response 
to TAG codon with MbPylRS, we next sought to characterize the catalytic 
competencies of the UAA in the absence of protein. Given directed evolution can 
only improve upon activity and not create it, it is preferential that the unnatural amino 
acid be a capable catalyst prior to incorporation into a protein host. An 
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intermolecular aldol reaction, a hallmark reaction for amine catalyst development, 
was chosen to evaluate enamine reactivity of ProK. This reaction was selected 
because it is amenable to high-throughput screening as demonstrated by its 
utilization in the computational design of aldolase enzymes (53). In addition, there 
are several commercially available or synthetically straightforward retro-aldol and 
aldol chromogenic/fluorescence probes with divergent structures and sizes that may 
facilitate future screening and directed evolution (53, 79, 80). We anticipate protein 
hosts will require sterically compatible substrates such that diverse and 
commercially available substrates provide ideal model systems. In addition, after 
installation of the UAA in a protein host, improvements in catalysis will be necessary 
by mutational exploration of the protein host. Reactions that exhibits a characteristic 
absorbance or fluorescence signature provide convenient screens for assessing 
improvements in catalytic competency among protein variants.  
 To begin, acetone and 4-nitrobenzaldehyde were selected as aldol 
substrates. Product standards were synthesized consistent with previous reports 
(81). HPLC and comparison to an internal standard [trans-beta nitro styrene (TBNS)] 
was used to quantity conversion via peak integration, Figure 2.7. The optimal 
reaction buffer was chosen after screening HEPES, phosphate and Tris HCl. 200 
mM potassium phosphate provided the largest conversion with minimal background 
reaction in the absence of catalyst, Figure 2.8. The reaction proceeded with 10% 
yield in the presence of 30 mol% ProK in 200 mM potassium phosphate buffer, pH 
7.4. Notably, ProK proved to be more active as a catalyst when compared to proline 
under these reaction conditions. Proline is an efficient aldol catalyst for this particular 
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reaction, however the reaction is typically performed in organic solvents, such as 
DMSO (57). We suggest the improved catalysis by free ProK may be the result of a 
phase separation where catalysis is occurring in a concentrated organic layer whose 
formation is more favorable with ProK than proline (82, 83).  
 To summarize our initial findings, we have designed an UAA that is 
incorporated by the WT MbPylRS in vivo, in response to a TAG codon in a protein 
sequence. This UAA is capable of aqueous aldol chemistry in a model reaction that 
has served as a means to screen protein catalysts in a high throughput fashion. 
Further, we have developed an analytical HPLC methodology to evaluate the 
catalytic conversion in the model reaction. The next step is to improve upon the 
incorporation efficacy of MbPylRS for ProK. Traditional organocatalytic reaction 
necessitate high catalyst loading (10-30 mol%) and we anticipate similar catalyst 
loading in our initial experiments evaluating aldol chemistry of ProK installed in a 
protein host.  
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Figure 2.7 Quantification of model aldol reaction 
(A) HPLC trace: an isocratic solvent system of 95:5 hexanes:ethanol was used at a flow rate of 1 
ml/min. Detection was monitored at 254 nm. Enantiomeric excess was not determined.  (B) aldol 
product standard curve: serial dilutions of a standard were performed. Internal standard at 5 mM was 
added to each sample and 5 µL was injected into Agilent LC 1260 Infinity II system.   
A
 38 
 
Figure 2.8 ProK catalyzed model aldol reaction 
(A) Model aldol reaction with corresponding HPLC trace of aldol product obtained at various 
concentrations of phosphate buffer. The optimized reaction conditions were determined to be 30 
mol% ProK, 200 mM phosphate, 400 mM Na+, 10 mM aldehyde, 100 mM acetone, pH 7.4. (B) 
Comparison of 30 mol% proline and ProK catalyzed aldol reaction in the optimized buffered 
conditions. 
 
2.2.5 Optimization of ProK incorporation by MbPylRS  
Previously, we determined that WT-MbPylRS incorporated ProK into GFP, in 
response to a TAG codon, roughly 10-fold less efficient than BocK, a positive UAA 
control. For future catalytic evaluation of ProK-containing proteins, however, we 
anticipate high catalyst loadings will be necessary, reflecting standard conditions for 
organocatalysic reactions in the literature. Accordingly, we next focused our efforts 
on the improvement of MbPylRS-mediated ProK incorporation. We first performed a 
series of experiments aimed at exploring vector-based effect on incorporation, in 
addition to improvements in ProK incorporation via mutation and evolution of the 
synthetase.  
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To begin, a comparative analysis between commonly utilized expressions 
systems was performed. A pET/pUltra and pBK/pBad dual plasmid systems have 
been developed and frequently used in our laboratory for unnatural amino acid 
mutagenesis (84, 85). These systems differ in location of tRNA and tRNA 
synthetase, as well as promoters for expression of all system components and the 
origins of replication. Notably, the fundamental principles of these two systems as it 
pertains to UAA expression are the same, however, in our experience, different 
UAA-containing proteins as well as different UAAs have shown disparate 
performances depending on the plasmid pair.  
We compared a pET-GFP-2TAG/pUltra-MbpylRS-MmpylT system with a 
pBK-MbpylRS/pBad-sfGFP149TAG.his-pylT system. By fluorescence intensity, 
expression of GFP was 2-fold greater with the pBK/pBad plasmid system than 
pET/pUltra. In addition, background incorporation of canonical amino acid 
incorporation in the absence of the unnatural amino acid was greater with the 
pET/pUltra system when compared to the pBK/pBad system, Figure 2.9. Moving 
forward with our optimized vector expression system for this particular protein and 
UAA, we transitioned to identifying improvements in incorporation efficiency by 
reaching out to mutations to the active site of MbPylRS that have been shown to 
improve the incorporation of similar UAAs. One mutation, Y349F, is known to 
improve amino acylation rates in PylRS (86). The Y349F mutation improved GFP 
expression in the presence of ProK by an additional 2-fold as judged by 
fluorescence intensity. Therefore, pBK-MbPylRS-Y349F served as our working 
plasmid for incorporating ProK and the target for further evolution efforts. 
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Quantification of ProK incorporation in GFP as determined by mass of purified 
protein obtained in the presence of BocK and ProK with MbPylRS-Y349F 
demonstrated 12% of the incorporation of the positive control with BocK.   
 
Figure 2.9 Optimization of UAA incorporation system for ProK 
(A) GFP fluorescence intensity after incorporation in the presence and absence, negative control, of 2 
mM ProK. (B) Improved florescence intensity observed with the mutation of tyrosine 349 to 
phenylalanine in MbPylRS, red curve, as compared to MbPylRS WT, blue curve.  
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2.2.6 Efforts towards the directed evolution of MbPylRS   
 Our previous efforts to increase incorporation efficiency of ProK by MbPylRS, 
which focused on the logistics of plasmid construction as well as a single known 
beneficial mutations, resulted in modest improvements. However, a single mutation, 
Y349F, provided improvements in ProK incorporation. This result suggested the 
possibility that other mutations to the PylRS scaffold may provide enhancement in 
incorporation efficiency. Therefore, we chose to carry out the direct evolution of the 
PylRS synthetase in an active site-directed manner. We employed a four site-
saturation “NNK” randomized library of MbPylRS that was created by a previous lab 
member, Joshua Gober. The sites chosen (see Figure 2.10) have all been shown to 
improve the incorporation of various N-ε-derivatized lysine UAAs (78). “NNK” codons 
(N = A,T,G,or C; K = T, or G), encoding all possible 20 canonical amino acids, were 
cloned onto the activating Y349F mutation to create pBK-MbPylRS-
Y349F/L305NNK/Y306NNK/L309NNK/C348NNK, Figure 2.10.  
 The library of mutant MbPylRS variants was selected for the ability to 
specifically suppress a TAG codon with ProK even in the presence of canonical 
amino acids through iterative rounds of positive and negative selection. For positive 
selections, we made use of a plasmid (pREP-pylT, Figure 2.10) harboring an 
antibiotic resistance marker, the chloramphenicol acyltransferase gene, embedded 
with a TAG codon (87). Cells were evaluated for growth in the presence of ProK and 
varying concentrations of chloramphenicol (80-200 µg/ml, depending on stringency 
of selection). Variants that survived the positive selection were then subjected to 
negative selection using a toxic protein encoding a TAG codon (pBad-Barnase-TAG, 
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Figure 2.10) (88). In this selection, cells were grown in the absence of ProK and 
expression of the toxic protein was induced using arabinose. Cells that survive the 
negative selection should be specific for ProK since the synthetase did not suppress 
the TAG codon with canonical amino acids. The detailed protocol for the selection is 
described in Positive/negative selection system 2.4.8. Multiple rounds of increasing 
chloramphenicol stringency followed by screening of 200 isolated colonies for 
improvements in GFP-based fluorescence resulted in no improved variants when 
compared to the parent, MbPylRS-Y349F. A reduced diversity library of Y271, L274 
and L270 NNK was carried through the same procedure and no improvements were 
identified. 
 
Figure 2.10 Direction evolution of MbPylRS via a 4 site-saturation ‘NNK’ library 
(A) MbPylRS, PDB ID: 2ZIM, with adenylated pyrrolysine shown in blue and residues targeted for 
‘NNK’ codons shown in yellow. (B) Plasmids used to select for improvements in ProK incorporation.  
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prone (EP) polymerase chain reaction (PCR) is an established means to introduce 
random nucleotide mutations in a gene sequence. We created EP libraries of the 
MbPyLRS-Y349F gene. The detailed EP PCR methodology is described in Error 
prone MbpylRS library and FAC sorting 2.4.9. Briefly, PCR reactions were 
performed with variations in the concentration of manganese chloride to decrease 
the fidelity of DNA polymerase in the presence of a thymine and cytosine biased 
nucleotide pool, to limit innate biases in nucleotide substitution patterns. The 
mutation rate of EP PCR reactions can be controlled by varying the MnCl2 
concentration. We found, libraries of MbPylRS-Y349F could be obtained containing 
low mutation rates (1-2 per gene) or high mutation rates (up to 8 mutations per 
gene). We examined two error prone libraries bearing either low mutation rates (~2 
per gene) to maximize the number of active synthetases in the library, or a high 
mutation rate (~6 per gene) to maximize mutational diversity. These libraries were 
co-transformed with pBad-sfGFP149TAG.his-pylT, to enable in cell screening of 
ProK incorporation via florescence assisted cell sorting, as described in Error prone 
MbpylRS library and FAC sorting.  
 As an alternative to antibiotic selections, fluorescence assisted cell sorting 
(FACS) based on GFP fluorescence was employed to identify mutants with 
improved ProK incorporation. Selections often enable large diversity libraries to be 
screened in parallel, but are hampered by increased instances of false positives. In 
addition, stringencies in selections may demonstrate a limited dynamic range if 
mutants are only slightly more active than wild type synthetases. Screens, such as 
FACS, provide a direct readout of cellular activity and hence quantitative PylRS 
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activity. We first validated our FACS screening methodology by successfully 
discerning cells harboring pBK-MbPylRS-Y349F from cells with pBK-MbPYlRS-WT, 
Figure 2.11, after GFP expression in the presence of ProK. Subsequently, the error 
prone libraries of pBK-MbPylRS-Y349F with high and low mutations per gene were 
co-transformed with pBad-sfGFP149TAG.his-pylT and subjected to florescence 
assisted cell sorting after expression overnight in the presence of 2 mM ProK. 
Unfortunately, evaluating 104 individual cells for GFP-based fluorescence did not 
identify further improvement in ProK incorporation, Figure 2.11.  
 
Figure 2.11 FAC sorting of error prone library fails to identify improvements 
(A) Population of cells expressing GFP with the WT-MbPylRS. (B) Mixture of cells expressing GFP 
with WT-MbPylRS and MbPylRS-Y349F. (C) Population of cells containing 6 mutations per MbPylRS-
Y349F gene created from error prone PCR with 0.15 mM MnCl2. No improvements to MbPylRS-
Y349F were identified.  
 
 Efforts to evolve a synthetase for ProK with improved incorporation efficiency 
above MbPylRS-Y349F were unsuccessful. We hypothesize that amino acid 
101
GFP Log
102 103100
8799
5866
2933
0
C
ou
nt
PylRS
A
101
GFP Log
102 103100
14994
9996
4998
0
C
ou
nt
PylRS
PylRS-Y349F
B
101
GFP Log
102100
18040
12027
6013
0
C
ou
nt
0.15 mM MnCl2 EP library 
+ 2 mM proK
PylRS-Y349F
C
 45 
degradation and/or inefficient cellular uptake are hindering incorporation yields. 
Experiments to access these and other possible limiting cause of ProK incorporation 
are underway. Despite the limited yields provided by MbPylRS-Y349F, this 
synthetase remains the most efficient system for ProK incorporation. Accordingly, 
we moved forward with effort to identify ProK-mediate catalysis in proteins using 
MbPylRS-Y349F for incorporation.  
2.2.7 Protein host selection and catalytic evaluation  
 The next step towards the creation of an enzyme equipped with a catalytic 
amino acid is to identify potential biomolecular scaffolds. The scaffold chosen should 
meet several criteria: (1) An ideal scaffold will be highly stable. Evolution can often 
lead to reduced protein stability due to deleterious mutations. We therefore focused 
on thermophilic proteins which operate at temperatures between 50 and 112 °C. 
Starting with thermophilic proteins increases the mutation potential without 
compromising stability. In addition, we focused our scaffold choices to proteins that 
are known to (2) express well in E. coli and (3) that contain large enough pockets to 
spatially accommodate the unnatural amino acid. Finally, we refined our search 
criteria to include (4) proteins that have previously been used as scaffolds for 
engineering since they are often well characterized and robust to mutagenesis.  
 Scaffolds were chosen based on previous successes in the engineering of 
metalloenzymes and computationally designed enzymes. Scaffolds with large 
hydrophobic cores such as the α/β barrels and jellyrolls are popular choices (36, 46). 
Three enzymes that adopt an α/β barrel fold, 2-deoxyribose-5-phophate aldolase 
(DERA), indole-3-glycerol phosphate synthase (IGPS) and a synthase subunit of the 
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glutaminase synthase enzyme complex (tHisF) were selected. Mechanistically, 
DERA represents a privileged scaffold in aldolase chemistry. It is the only aldolase 
to catalyze the reaction between two aldehyde substrates. IGPS is an interesting 
scaffold that contains a wide opening on one side of the α/β barrel, termed the 
catalytic face. This face has been used in the design of a copper-binding site which 
was used in a catalytic Diels-Alder cycloaddition in the related imidazole-3-glycerol 
phosphate synthase. The authors were able to make seven mutations to the scaffold 
including four mutations of histidine to alanine without any negative effects in 
expression and folding (89). In the Baker lab, IGPS has been computationally 
remodeled as a retro-aldolase and DERA was redesign as a Kemp eliminase (53, 
90). Both non-natural activities were improved upon using directed evolution (91). 
tHisF has been demonstrated as a robust host for the creation of artificial 
metalloenzymes and a suitable host for bulky organocatalysts. It is also very tolerant 
to mutations and simply purified from endogenous proteins by heat denaturation (35, 
92). The genes encoding these proteins were obtained from LifeTechnologies as 
GeneArt Strings DNA Fragments and cloned into the pET21C(+) using the NdeI and 
XhoI restriction enzyme sites. The genes were amplified with primers containing 
NcoI and PmeI and subsequently digested and ligated into pBad_pylT backbone, 
see Primer Sequences 2.5.2. 
 Scaled preparation of the scaffold proteins was carried out followed by 
evaluation of aldol catalysis in the model reaction between acetone and 4-
nitrobenzaldehyde. The protein host for the catalytic unnatural amino acid should not 
perform the reaction on its own. Both IGPS and DERA displayed significant product 
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formation in the reaction as judged by HPLC analysis of the reaction in the presence 
of 5 mol% protein, 10 mM aldehyde and 100 mM acetone in phosphate buffer, 
Figure 2.12. Therefore, ProK engineering efforts with these two scaffolds will require 
prior mutagenesis to knock out this background catalysis. Wild type tHisF did not 
catalyze the reaction above background in the absence of catalyst and could be 
moved forward to ProK incorporation directly.  
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Figure 2.12 Evaluation of aldol activity in wild type scaffold proteins 
HPLC traces of the reaction between 4-nitrobenzaldehyde and acetone with 5 mol% scaffold protein 
in optimized buffered conditions (A) DERA, PDB ID: 2UB3, demonstrates near complete conversion 
of the model aldol reaction. (B) tHisF, PDB ID: 1THF, does not catalyze the model aldol reaction. (C) 
IGPS, PDB ID: 1CV4, is efficient at the model aldol reaction. 
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substituted aromatic acceptor substrate (93). DERA has two active site lysine 
residues (K151 and K180) that are crucial for its wild type chemistry, the conversion 
of 2-deoxy-D-ribose 5-phosphate to D-glyceraldehyde 3-phosphate and 
acetaldehyde. This reaction proceeds via a organocatalysis mechanism that requires 
the nucleophilic attack of lysine 151 on the aldehyde of the substrate. The 
nucleophilicity of K151 is made possible by the pKa perturbation in response to the 
second lysine residue, K180, which sits adjacent to K151. We hypothesized that 
these two lysines are the primary source for the background catalysis in our model 
reaction. To test this hypothesis, either the catalytic lysine or the pKa perturbing 
lysine was individually mutated to alanine and both alanine mutations eliminated 
aldol chemistry between acetone and 4-nitrobenzaldehyde, Figure 2.13. 
 A similar rational targeted mutagenesis effort to eliminate promiscuous aldol 
catalysis by IGPS was not undertaken. The native IGPS reaction, conversion of 1-(o-
carboxyphenylamino)-1-deoxyribulose 5-phosphate into indole-3-glycerol phosphate, 
is catalyzed by an intricate interplay of several residues and dependent on 
conformation loop changes (94). Based on the complexity of this system, multiple 
mutations may be required to completely attenuate background catalysis and 
identifying rational mutations is not straight forward. Therefore, this protein was 
removed from future work. Since tHisF shows no aldol catalysis and we have 
identified point mutants of DERA that are also clear of background chemistry; these 
two protein scaffolds were selected for subsequent ProK-catalysis experiments.   
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Figure 2.13 Elimination of WT-DERA aldol catalysis 
 
2.2.8 Incorporation of ProK within protein scaffolds 
 We next sought to identify locations within the engineered DERA and tHisF to 
incorporate ProK, beginning with DERA as a target scaffold. In collaboration Dr. 
Chris Snow at Colorado State University, ProK was modeled in place of K151 or 
K180. Since ProK is a lysine analog, we hypothesized that these locations may be 
able to accept the non-natural lysine derivative (Figure 2.14). To further refine 
optimal location, the intermediate iminium ion as a result of acetone condensation on 
the amine was also modeled, Figure 2.14. This modeling identified two solutions with 
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incorporation. Protein expression was evaluated in the presence and absence of 
BocK and the clarified lysate was evaluated by SDS-PAGE, as described Small 
scale UAA incorporation  2.4.4. As shown in Figure 2.15, no location proved suitable 
for the generation of a ProK containing protein, as only small increases in DERA 
expression was obtained in the presence of amino acid when compared to no amino 
acid controls.   
 
Figure 2.14 Computational selection of residues in DERA to host ProK 
(A) Representation of proline amide modeled on the backbone of lysine in the active site of DERA, 
PDB ID: 1UB3. (B) Adduct after nucleophilic attack of ProK on acetone modeled in a hydrophobic 
pocket of the DERA scaffold. Alanine mutations to accommodate ProK are shown in orange.  
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Figure 2.15 Searching locations within DERA to incorporate ProK 
SDS-PAGE gel showing expression of DERA-TAG mutants in the presence and absence of 2 mM 
BocK. No location was found to host the UAA. Lysine residues tested for UAA incorporation are 
shown in yellow. 
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variants. Of the TAG locations tested (L2, L50, T171, L169, L3, N22, N24, R27, 
I199, I7) L50, T78 and L169 resulted in significant production of BocK containing 
protein, Figure 2.16. Accordingly, we next examined incorporation of ProK at these 
three locations. While Bock provided robust yields at all three sites, scaled 
preparation of ProK-containing tHisF in LB media supplemented with 4 mM ProK 
yielded (at the best location, tHis-F50ProK), significantly lower yields (<0.5 mg of 
protein per 2-liter expression). Mass spectrometry was used to verify successful 
incorporation of ProK and BocK into tHisF at location 50, Figure 2.17. Auto-induction 
media using pET/pUltra system was also tested in an attempt to increase yields of 
tHisF50ProK. This plasmid system and media combination have been shown to 
improve protein yields for unnatural tyrosine analogs (95). However, previous 
experiments using this pET derived plasmid have shown increased background 
incorporation of canonical amino acid incorporation compared to the pBK/pBad 
system, Figure 2.9. This background incorporation was exacerbated when applied 
towards ProK in auto-induction media. 
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Figure 2.16 Searching tHisF for locations to install ProK 
SDS-PAGE gel showing expression of tHisF dependent on the presence of 2 mM BocK at locations 
L50, T78 and L169.  Residues chosen to host UAA are shown in yellow.  
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Figure 2.17 Mass spectrometry analysis of tHisF50ProK and tHisF50BocK 
 
2.2.9 Evaluating the reactivity of a ProK containing protein scaffold 
  Despite its poor expression, tHisF50ProK was selected for further evaluation 
and we next sought to evaluate the nucleophilicity of the proline moiety within the 
hydrophobic cavity of tHisF. Enamine and/or iminium ion catalysis requires the 
amine of proline to be deprotonated in order to perform nucleophilic attack on the 
carbonyl of the electrophile in the reaction. A simple means to evaluate whether an 
amine is reactive as a nucleophile is reductive amination or imine trapping. In this 
experiment, the amine and electrophile are incubated in solution with a water-soluble 
reductant, in this case, sodium cyanoborohydride (NaCNBH3). If condensation of the 
amine on the carbonyl occurs, the resulting iminium ion is reduced by NaCNBH3 to 
form an amine, Figure 2.18. The result is a covalently modification that is observable 
by mass spectrometry. This method is used as a screen to identify potential 
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electrophilic substrates, such as screening various ketone and/or aldehyde 
containing compounds (96). It can also be used to evaluate the reactivity of the 
amine by screening different concentrations of the carbonyl compound and 
determining at which concentration the adduct is observed.  
 
Figure 2.18 Mechanism of model aldol reaction and reductive amination. 
 
 Reductive amination was used to evaluate the potential for amine-based 
catalysis by tHisF50ProK. The amine of proline, if poised for nucleophilic attack, will 
form a covalent adduct with acetone indicated by a mass shift of 42 Daltons (Da). As 
positive controls, ProK as a free amino acid and the aldolase scaffold, DERA, were 
reacted with acetone and sodium cyanoborohydride. A detailed procedure is outlined 
in Reductive amination 2.4.11. The covalent adduct (42 Da) corresponding to 
reductive amination of acetone was observed for free ProK at 100 mM acetone and 
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at 1 mM acetone for DERA. However, no such adduct was observed for tHisF 
containing ProK in the presence of acetone (1, 10 and 100 mM) and reductant, 
Figure 2.19. This result implies that either the amine of ProK is protonated and 
therefore either solvent exposed or inclusion in the hydrophobic pocket does not 
drop the pKa to a sufficient extent. Alternatively, the amine is deprotonated and 
acetone is unable to locate the reactive UAA, this outcome seems unlikely and is 
discussed further in the conclusions.  
 
Figure 2.19 Reductive amination evaluates nucleophilicity of tHisF50ProK 
Incubation of reactive amine in acetone with and without NaCNBH3 demonstrates covalent 
modification of free ProK and DERA but not tHisF50ProK.   
 
2.2.10 PyrrolK, the carbamate version of ProK   
Thus far, the creation of a protein catalyst via the installation of a catalytic 
UAA has been limited by the yield of protein acquired due to poor incorporation 
efficacy of ProK by MbPylRS. Efforts to improve incorporation efficiency via directed 
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evolution were unsuccessful. Therefore, we decided to alter the structure of the UAA 
in hopes to create a structure to host proline that is more amenable to the active site 
of MbPylRS. It has been previously demonstrated that UAAs with carbamate 
linkages between lysine and an appendage are incorporated by PylRS with greater 
efficiency than the corresponding amide linkages (97, 98). This presents an 
opportunity to tweak the structure of our proline-lysine linked UAA.  
 We designed and synthesized, PyrrolK, a carbamate version of ProK. The 
UAA was designed to be structurally and chemically similar to ProK and was 
inspired from N-e-cyclopentyloxycarbonyl-L-Lysine (UAA #6, Figure 2.4), a known 
substrate for the wild type MbPylRS. By taking this design approach, we 
hypothesized we could utilize the same ‘NNK’ and EP PCR MbPylRS libraries that 
were created for ProK in the directed evolution of a synthetase for PyrrolK. In 
addition, knowing that MbPylRS has stereo-specificity for D-prolyl-lysine over L-
prolyl-lysine, we decided to synthesize both R and S enantiomerically pure forms of 
PyrrolK to evaluate the preference, if any, of the synthetase for enantiomers of 
PyrrolK. The synthetic route for this amino acid is described in detail in the Small 
molecule synthesis and characterization 2.5.3., section. Briefly, Boc protected 
enantiomerically pure R or S hydroxy-D-proline was activated with N,N’-
disuccinimidyl carbonate and then coupled to N-a-boc-L-lysine. The amino acid 
synthesis was characterized by mass spectrometry.  
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Figure 2.20 PyrrolK 
(A) Structure of (R) and (S) PyrrolK. (B) Extracted ion chromatogram of mass corresponding to 
PyrrolK.  
 
After construction of the two enantiomers of PyrrolK, we set out to test 
whether the UAA is a substrate for the WT-MbPylRS. Again, we employed a simple 
GFP-based experiment in which successful TAG suppression is indicated by full 
length gene expression and therefore, fluorescence, and the intensity gives a 
qualitative assessment of the efficiency. It was found that the UAA was weakly 
incorporated in both R and S forms by the WT-MbPylRS at position 149 in GFP. 
Incorporation efficiency was determined to be 4 percent of the incorporation of the 
positive control with BocK.  
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Before tackling a directed evolution for PyrrolK, we first evaluated a few 
mutants of MbPylRS as an initial investigation into whether the active site-directed 4 
site ‘NNK’ library may provide improved incorporation. A small set of MbPylRS 
mutants, identified by previous lab member, Joshua Gober, that contain mutations 
favorable for incorporation of different carbamate UAAs were subjected to the GFP-
based fluorescence analysis. A mutant, MbPylRS-L274A/C313S/Y349F displayed 
greater fluorescence intensity than the WT-MbPylRS in the presence of R and S 
PyrrolK, Figure 2.21A. This suggested that carrying out iterative rounds of positive 
and negative selections with the four-site ‘NNK’ library might provide additional 
improvements. The selection protocol, as described for ProK, was repeated in the 
presence of R and S PyrrolK, separately. Two rounds of positive selection with 80 
μg/ml Cm followed by negative selection and screening 200 mutants for GFP 
florescence revealed a mutant with an improvement from WT-MbPylRS for R 
PyrrolK, MbPylRS-YL274A/C313V/Y349F. An additional round of positive selection 
with increased stringency at 200 μg/ml Cm did not provide further improvements.  
No further improvements were identified for S PyrrolK. 
The incorporation efficiency of MbPylRS-YL274A/C313V/Y349F, the mutant 
identified from directed evolution was quantitatively assessed. The mass of purified 
protein obtained after expression of GFP-TAG in the presence of 2 mM PyrrolK was 
compared to the mass of purified protein obtained from expression of GFP-TAG in 
the presence of Bock by the WT-MbPylRS. Expressions were carried out on a 
preparative scale and full-length GFP was purified by His-tag affinity 
chromatography as described in Protein expression, purification and 
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characterization. It was determined that MbPylRS-YL274A/C313V/Y349F produced 
an increase from 4 percent (WT-MbPylRS) to 28 percent of the incorporation of the 
positive control of BocK, Figure 2.21B.  
 
Figure 2.21 Evolution of MbPylRS for PyrrolK 
(A) Qualitative comparison of incorporation efficiency of PyrrolK by MbPylRS variants. (B) 
Quantitative comparison of the incorporation efficiency of PyrrolK by the MbPylRS variant identified 
from directed evolution to the incorporation of BocK by the WT-MbPylRS. 
 
As with ProK, creation of an optimized synthetase for incorporating the UAA 
into a protein sequence, in vivo, in response to TAG codons, called for the 
subsequent evaluation of the catalytic performance of PyrrolK. Therefore, PyrrolK 
was evaluated in the aldol model reaction between acetone and 4-
nitrobenzaldehyde. The reaction conditions were optimized as before by screening 
buffers, HEPES, Tris HCl and phosphate at pH 7.4.  Phosphate was found to be the 
preferred buffer resulting the highest yields with the smallest conversions in the 
absence of catalyst. PyrrolK was determined to catalyze the reaction to a similar 
extent as ProK, Figure 2.22.   
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Figure 2.22 Buffer optimization of PyrrolK aldol reaction 
The reaction conditions are as follows, 200 mM buffer, pH 7.4, 10 mM 4-nitrobenzaldehyde, 100 mM 
acetone, 10 mol% catalyst. aldol product concentration was determined via peak integration of HPLC 
chromatograph and method of internal standard using 5 mM TBNS.   
 
Further efforts to press on with the installation of PyrrolK into protein scaffolds 
was impeded by complications in subsequent batches of PyrrolK that were 
synthesized. Incorporation by MbPylRS-YL274A/C313V/Y349F was not reproducible 
with the second batch of synthesized PyrrolK and therefore efforts with PyrrolK as 
an organo-catalytic unnatural amino acid were halted. However, this UAA 
demonstrated the most promising incorporation efficiency, if repeated, by MbPylRS 
of all three UAAs, Pro4AF, ProK and PyrrolK. Incorporation of PyrrolK into tHisF at 
locations found suitable for hosting ProK and evaluating the reactivity of the amine 
via reductive amination experiments are of future interest. 
2.3 Conclusions  
The production of enantioselective organocatalysts for enamine/iminium ion 
chemistry under aqueous conditions has been the focus of extensive research over 
the last 50 years (82, 99-102). Designing small molecules that can enrich for a single 
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enantiomer via the controlled orientation of substrates in a reaction’s transition state, 
is not trivial. A commonality among successful catalysts is the proline or pyrolidine- 
catalytic centers (68, 81). If used as a single enantiomer, proline organizes the 
transition state of the reaction in a manner that transfers chirality to the formation of 
products (103). The transition state architecture of proline-catalyzed reactions was 
further promoted by the creation of more sterically complex and/or densely 
functionalized secondary- amine organocatalysts, Figure 2.23. These catalysts 
demonstrate improved enantioselectivities as compared to free proline (99). 
Enhanced catalysis was later attributed to the formation of emulsions and biphasic 
systems that sequester organic substrates and hydrophobic reactive centers within a 
concentration organic layer where the reaction occurs isolated from water (104), 
reminiscent of an enzymatic hydrophobic active site. However, even the best small 
molecule organocatalysts fail to produce synthetically useful enantio-inductions 
(104). 
 
Figure 2.23 Example complex proline/ pyrolidine organocatalysts 
 
In terms of a stereoselective “organocatalyst”, few catalysts challenge the 
selectivities of biomolecular scaffolds for their native substrates (105). Enzymatic 
enantioselective enamine catalysis is carried out by type I aldolases that use a 
catalytic lysine residue for nucleophilic attack and enamine formation. The active site 
of aldolase enzymes is extremely complex. It is composed of several networks of 
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salt bridges and poised water molecules that orchestrate the reduction of the pKa of 
lysine, binding and positioning the substrate and catalysis (106). Therefore, 
engineering aldolases for non-natural enamine/iminium catalysis is challenging as 
demonstrated by computationally designed retroaldolases with best designs having 
catalytic efficiencies (kcat/KM) of 1-100 M-1s-1, compared to natural enzyme’s kcat/KM 
of 105-109 M-1s-1 (106, 107). Further, aldolases demonstrate limited substrate 
tolerance and must be engineered to accept non-phosphorlyated substrates (106). 
Although aldolases have proven difficult to adapt for non-natural aqueous 
organocatalysis, an exemplary success in the engineering of protein scaffolds is 
highlighted by the creation of catalytic antibodies (108-110). In fact, they are credited 
as the first, tailored, aqueous organocatalysts with high enantioselectivities (104).  
In nature, enamine catalysis is confined to the reactivity of the amine in the 
lysine side chain. Proline catalysis does not exist.  The lone pair of the nitrogen atom 
participates in amide bond formation with the sequential residue and therefore 
cannot act as nucleophile. However, there is a single example of a protein 
preforming non-natural proline-based enamine catalysis. The enzyme, 4-
oxalocrotonate tautomerase (4-OT), contains an amino-terminal proline that, in its 
natural reaction, acts as a general base. The pKa of the terminal proline, 6.4, is 
attenuated by the active site pocket in which it rests and therefore deprotonated at 
physiological pH (111). The enzyme was found to promiscuously catalyze the aldol 
reaction between acetaldehyde and benzaldehyde to form cinnamaldehdye and the 
Michael-type addition of acetaldehyde to TBNS. Both transformations proceed 
through proline catalyzed enamine formation of acetaldehyde, Figure 2.24 (112). 
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Amino-terminal tautomerases are an isolated class of protein-based proline 
catalysts. The enamine reactivity is the result of an evolved hydrophobic pocket 
specifically adapted to tune the pKa of proline.  
 
Figure 2.24 Promiscuous enamine chemistry of 4-OT 
 
This chapter described our efforts towards aqueous organocatalysis by a 
proline-containing protein scaffold. Our strategy was to install a proline-catalyst, in 
vivo, via unnatural amino acid mutagenesis. We report the synthesis for two original 
UAAs, Pro4AF and PyrrolK, and both synthetic strategies are designed for scaled-
preparation. The in vivo incorporation of a proline (ProK) and a pyrolidine (PyrrolK) 
containing unnatural amino acid by the WT-MbPylRS was successful. Further, we 
describe the identification of a mutation that improves incorporation of ProK, 
MbPylRS-Y349F and the evolution of a synthetase for PyrrolK, MbPylRS-
YL274A/C313V/Y349F. Pro4AF, a tyrosine-based proline UAA was synthesized 
however no synthetase was identified for its incorporation into protein sequences. 
The UAAs, ProK and PyrrolK, were demonstrated as capable catalysts, at high 
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catalyst loading, in a model aldol reaction between acetone and 4-
nitrobenzladehyde. Lastly, a suitable protein scaffold to host the UAAs was 
identified, tHisF, and tHisF containing proK was subsequently evaluated for aldol 
catalysis.  
Herein, the engineering of a catalytic-UAA containing protein scaffold was 
hindered by poor incorporation of proline/pyrrolidine-containing lysine-based UAAs 
by MbPylRS. Efforts to evolve a synthetase for the incorporation of ProK, either by 
active-site directed site-saturation mutagenesis or by error prone PCR of the entire 
synthetase scaffold, were unsuccessful. Therefore, we were only able to produce 
minute amounts of UAA-containing protein (on average, <0.25 mg per liter of 
expression), hindering efforts to characterize the catalytic capabilities of the naïve 
UAA-containing protein scaffold. For free ProK aqueous aldol catalysis, standard 
organocatalyst loadings of 30 mol% were necessary. We were unable to recreate 
these reaction conditions with our proline-containing protein, and the reaction did not 
proceed at the catalyst loading we investigated, <1 mol%. Because no starting aldol 
activity was observed, we were unable to employ directed evolution mutagenesis 
and screening experiments.  
Proline, with a pKa of 10.6, is protonated at neutral pH. Nucleophilic attack of 
an amine can only occur by a free lone pair of electrons. On the basis of successes 
in the field of small molecule organocatalysis by sequestering the reaction to a 
concentrated organic layer, and the promiscuous catalysis by 4-OT, we 
hypothesized that confining a proline-based organocatalyst within a protein scaffold 
would provide initial, weak, activity, in an enamine-based reaction. We anticipated 
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that the confinement would also alleviate the high catalyst loading associated with 
free organocatalysts in solution, by protecting the catalyst from degradation and 
inactivation by electrophiles in the media. However, we discovered that this was not 
the case given our proline-UAA containing protein demonstrated no aldol activity at 1 
mol% catalyst loading. Diagnostic experiments were performed to evaluate the 
ineffectiveness of tHisF50ProK at aldol chemistry. Reductive amination experiments 
suggest either the pKa of proline within tHisF is poorly suited for nucleophilic attack, 
or acetone was unable to locate the amine of ProK, the later seems unlikely. The 
aldolase, DERA, has a similar fold and hydrophobic pocket and is very efficient at 
catalyzing the reaction via nucleophilic attack of lysine on acetone, as proved by 
reductive amination experiments. To further probe whether substrate access or pKa 
is preventing catalysis, we planned to install ProK at a surface residue in tHisF and 
then perform reductive amination. However, all surface residues tested did not 
accept UAAs, Figure 2.16.   
Despite the lack of catalysis by our proline-UAA-protein scaffold, this work 
presents ground work towards the creation and incorporation of amino-catalytic 
UAAs. Proline, the earliest and most extensively explored secondary amine catalyst 
fosters both enamine and iminium ion chemistry and has been proven capable of an 
impressive number of transformations (68). Even so, the stereo- and regio-selectivity 
is limited by the structurally simple nature of the small molecule catalyst and access 
to reactions such as aldehyde-aldehyde couplings are still confined to enzymatic 
systems (68, 93). Our goal of incorporating a reactive proline entity within a protein 
scaffold which can be engineered to accept various substrates through directed 
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evolution, is relevant. This approach will exploit the enantioselectivities inherent to 
protein scaffolds while circumventing the engineering difficulties associated with 
adapting aldolase enzymes and catalytic antibodies for applied chemical synthesis. 
However, the inability to recreate proline catalysis within a protein scaffold highlights 
the exquisite ability of nature to fine tune biomolecular scaffolds for a particular 
function in a manner specific to its unique substrate.  
2.4 Materials and Methods 
2.4.1 Protein expression, purification and characterization 
 Plasmids pET-GFP2TAG, pBad-sfGFP149TAG, pBK-MbPylRS, pUltra- 
MbPylRS, pREP-pylT, pBad-Barnase2TAG, pEvol-aaRS-tRNACUAMjTyr were 
acquired and used without manipulation from common lab supplies. Acetone, 4-
nitrobenzaldehyde, trans-beta nitrostyrene, ampicillin, tetracycline, chloramphenicol, 
kanamycin, streptomycin were acquired from commercial sources and used without 
further purification. Antibiotics were used at the following concentrations, 100 µg/mL 
ampicillin, 25 µg/mL tetracycline, 40 µg/mL chloramphenicol, 50 µg/mL kanamycin 
and 50 µg/L streptomycin. 
2.4.2 Amino acid toxicity test 
 A diagnostic toxicity test was performed for each unnatural amino acid. A 
single colony of DH10B competent cells (ThermoFisher) or Bl21-Gold(DE3) 
competent cells (Agilent Technologies) cells was used to inoculate 5 mL overnight 
cultures in LB and LB plus 1 mM unnatural amino acid. The cultures were grown to 
saturation overnight at 37 °C with shaking (225 rpm) and the optical density (OD) at 
600 nm was determined.  The OD in the presence of unnatural amino acid did not 
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differ from the culture grown in absence of unnatural amino acid, for Pro4AF, ProK, 
nor PyrrolK.  
2.4.3 Plasmid construction and mutagenesis 
 Genes for Thermus thermophilus deoxyribrose-phosphate adolase (DERA), 
Thermus thermophilus Indole-3-glycerol phosphate synthase (IGPS) and 
Thermotoga maritima Histidine synthase F (tHisF) were ordered as GeneArt DNA 
strings with NdeI and XhoI cutsites from ThermoFisher Scientific. The DNA 
fragments and pET21C(+) were digested with NdeI and XhoI followed by ligation 
with NEB T4 DNA ligase at 16°C overnight.  A 6X-C-terminal histidine tag was 
included. Amber stop codons were cloned using a BsaI-based cloning strategy. All 
TAG containing constructs were also cloned into the pBad-pylT backbone through 
amplification of the gene with NcoI and PmeI containing primers followed by 
restriction enzyme digest and ligation. All plasmids were verified by sequencing and 
restriction enzyme digests.  
2.4.4 Small scale UAA incorporation  
 An individual colony was used to inoculate a starter culture in Luria-Bertani 
media (LB) supplemented with appropriate antibiotics. The culture was incubated at 
37°C with shaking (225 rpm) overnight. 50 μL of this starter culture was used to 
inoculate three falcon tubes with 5 mLs LB media and antibiotics.  To one culture, 
unnatural amino acid (typically 2 to 4 mM) was added from a stock 100 mM solution 
in water.  To another, BocK was added to 1 mM final concentration.  The third 
served as a negative control with no supplemented amino acid. The cultures were 
grown to an optical density at 600 nm of 0.6 after which expression was induced by 
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the addition of 0.5 mM isopropyl β-D-1-thiogalactopyranoside (pET, pUltra) or 0.2% 
arabinose (pBad, pBK). The cultures were incubated at 37°C with shaking overnight.  
The culture was pelleted by centrifugation at 1000g for 10 minutes.  The supernatant 
was discarded and the pellet resuspended in 500 µL PBS with 0.25 mg/ml lysozyme.  
The slurry was transferred to an Eppendorf tube and incubated at 37°C for 30 
minutes.  The cells were then further lysed by sonication, 20% amplitude, 20 
seconds at 50% duty cycle. The lysate was clarified by centrifugation at 15000 rpm 
for 10 minutes. 10 µL of the lysate was combined with 10 µL of 2X SDS load dye 
and 10 µL was ran on the gel. For GFP analysis, the clarified lysate was evaluated 
as described in GFP fluorescence measurements.  
2.4.5 Large scale scaffold protein preparation 
 An individual colony was used to inoculate a starter culture in Luria-Bertani 
media (LB) supplemented with appropriate antibiotics. The culture was incubated at 
37°C with shaking (225 rpm) overnight. This starter culture was used to inoculate a 1 
L flask of LB supplemented with appropriate antibiotics and unnatural amino acid (2 - 
4 mM). The culture was grown to an optical density at 600 nm of 0.6 after which 
expression was induced by the addition of 0.5 mM isopropyl β-D-1-
thiogalactopyranoside (pET, pUltra) or 0.2% arabinose (pBad, pBK). The expression 
was carried out for 18 hours.  The cells were then pelleted by centrifugation at 1000g 
for 30 minutes. The supernatant was discarded and the cells resuspended into 25 
mL of buffer A (50 mM NaH2PO4, 30 mM imidazole, 150 mM NaCl, pH 8.0) 
supplemented with 0.5 mg/ml lysozyme. Cells were sonicated using a Fischer 
Scientific Sonic Dismembrator model 500 for 8 min at 20% amplitude at a 39% duty 
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cycle.  Lysates were clarified by centrifugation at 27,000g for 1 hour, passed through 
a 0.22-μm filter and loaded on to a pre-equilibrated with buffer A Ni-NTA HisTrap HP 
column (5 ml HisTrap HP, GE Healthcare) using an AKTA Purifier (GE Healthcare). 
The column was washed with buffer A followed by a step elution to 10% buffer B (50 
mM NaH2PO4, 300 mM imidazole, 150 mM NaCl, pH 8) to remove nonspecifically 
bounds proteins. The scaffold protein was eluted with 55% B. The protein was buffer 
exchanged into PBS using Amicon Ultra-10 centrifugal filters (EMD Milipore).  A heat 
purification followed in which the protein was incubated at 70°C for 10 minutes to 
precipitate contaminating proteins.  Concentrations were determined by nanodrop 
with extinction coefficient and molecular weight calculated from Scripps protein 
calculator. Purity of the protein was judged as >90% by SDS-PAGE and mass 
spectrometry on Agilent 6520 Accurate Mass QTOF LC-MS ESI positive in high-
resolution mode. 
2.4.6 GFP-based synthetase screen for Pro4AF incorporation 
 BL21 DE3 Gold cells (Agilent Technologies) harboring both pET22b(+)-
sfGFP2TAG.his and pEvol carrying a unique synthetase and the cognizant 
tRNACUAMjTyr were inoculated into individual wells of a 96 well block containing 1 ml 
of LB media supplemented with 100 µg/mL ampicillin (amp) and 40 µg/mL 
chloramphenicol (cam). The block was incubated at 37 °C with shaking (980 rpm) 
overnight.  This block was used to inoculate individual wells of a block containing LB 
amp/cam and 2 mM Pro4AF and a negative control block containing only LB 
amp/cam.  The cultures were grown until at OD 0.6 when expression was induced 
by the addition of 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG).  The blocks 
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continued shaking overnight after which the cells were pelleted at 1000g for 15 
minutes. The supernatant was discarded and the cells resuspended into 500 µL of 
phosphate buffered saline with 0.25 mg/ml lysozyme added. The blocks were carried 
through 5 rounds of freeze thaw from -80°C to room temperature.  The lysate was 
clarified by centrifugation at 1000g for 30 minutes. Fluorescent measurements were 
performed on clarified lysate.  
2.4.7 GFP fluorescence measurements 
 Fluorescence measurements of clarified lysate or purified protein were carried 
out on Tecan M1000 PRO UV/Vis plate reader in 96 well clear plates by excitation at 
488 nm and monitoring emission from 500 to 600 nm.  Gain was set to the well of 
the positive control of BocK incorporation for each experiment.  
2.4.8 Positive/negative selection system 
  200 to 500 ng of pBK-MbPylRS-
Y349F/L305NNK/Y306NNK/L309NNK/C348NNK was transformed into DH10B 
electrocompetent cells containing pREP pylT.  The number of transformations was 
adjusted to cover the diversity of library, 1*107 transformants. The rescue was used 
to inoculate 50 mLs of LB supplemented with kan and tet and grown to saturation.  1 
mL of the saturated culture was used to inoculate 100 mL of LB-kan-tet containing 1 
mM unnatural amino acid. The culture was incubated at 37 °C for 3 hours after 
which chloramphenicol was added to 80 μg/ml and then grown to saturation.  A 
second positive selection was carried out by inoculation of 100 mL of LB-kan-tet 
containing 1 mM unnatural amino acid with 0.5 mL of positive selection round 1.  
This culture was grown to saturation followed by centrifugation of 20 mLs at 1000g 
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for 30 minutes.  The culture was miniprepped and the pBK- MbPylRS 4 site ‘NNK’ 
library was purified from the pREP-pylT by agarose gel electrophoresis followed by 
gel extraction.  
 A negative selection was carried out by co-transformation of 200 ng of 
positive selection round 2 library in pBK with 200 ng of pBad-barnase-
Q2TAG/D44TAG.  The rescue was used to inoculate 100 ml of LB-kan-tet containing 
0.2% arabinose to induce expression of the barnase gene. The culture was 
incubated at 37 °C over night.  20 mLs of the negative selection was miniprepped 
and the pBK- MbPylRS 4 site ‘NNK’ library was gel purified from the pBad negative 
selection plasmid. 
 The resulting library was then subjected to a GFP based screen to identify 
synthetase hits that are selective for the unnatural amino acid. 100 ng of the pBK- 
MbPylRS 4 site ‘NNK’ library was co-transformed with pBAD-sfGFP149TAG-pylT. 1 
mL of LB-kan-tet in individual wells in two 96 well blocks were inoculated with a 
single transformant. The block was grown to saturation overnight at 37 °C with 
shaking (990 rpm).  50 μL of each well from this block was used to inoculate 
individual wells of a fresh block containing 1 ml LB-kan-tet with 2 mM unnatural 
amino acid and a second block containing 1 mL LB-kan-tet.  The blocks were grown 
for 2 hours at 37 °C with shaking after which arabinose was added to 0.2%.  The 
blocks were incubated overnight followed by centrifugation at 1000g for 10 minutes. 
The supernatant was discarded and the blocks were lysed and clarified as 
previously described. 250 μL of the clarified supernatant were transfer to a black 96 
well florescence plate and the emission spectra was recorded. 
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2.4.9 Error prone MbpylRS library and FAC sorting  
 Error prone PCR was carried out on 10 ng of MbPylRS-Y349F using the 
following primers, MbPylRS -SacI-F (GATGTTGAGCTCATGATG GATAAAAAACCG 
CTGG) and MbPylRS -SalI-R (GATGTTGTCGACTTACAGGTTCGTGCTAATGC) at 
0.3 μM and Taq polymerase. Manganese chloride concentrations ranged from 0.15 
mM to 0.05 mM. Magnesium chloride was held at 5.5 mM.  0.2 mM dGTP, 0.2 mM 
dATP, 1 mM dCTP and 1 mM dTTP were used. Ligations were carried out 16 °C 
overnight using a three to one ratio of SacI, SalI digested MbPylRS-Y349F library to 
SacI, SalI digested pBK backbone. The ligation was transformed into DH10B cells to 
obtain a minimum of 1*106 transformants.  The rescue was used to inoculate 50 mLs 
of LB-kan-tet and grown to saturation overnight.  20 mL of the culture was 
miniprepped to isolate the library.  The library was transformed with pBad-
sfGFP149TAG-pylT in DH10B cells.  The rescue was used to inoculate 50 mL LB-
kan-tet and grown over night.  50 μLs of this culture was used to inoculate 5 mLs of 
LB-kan-tet with 2 mM unnatural amino acid and 5 mL of LB-kan-tet. The cultures 
were grown to an optical density of 0.6 at 600 nm followed by addition of 0.2% 
arabinose.  After expression of GFP occurred overnight at 37 °C with shaking, cells 
were evaluated on a Beckman Coulter MoFlo. Only cells demonstrating florescence 
intensity above the control expression of DH10B cells harboring the pBK- MbPylRS-
Y349F parent and pBad-sfGFP149TAG-pylT were collected in LB media.  The 
media was plated on LB-Kan-Tet agar and individual colonies were grown to 
saturation, miniprepped and sequenced.  
2.4.10 Aldol reaction 
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 Small scale protein reactions were performed in Agilent screw top clear glass 
vials equipped with a stir bar.  Acetone was added to 200 mM from a 20X stock in 
water.  4-nitrobenzaldehyde was added to 10 mM from a 50 X stock in DMSO. 
Lastly, catalyst was added from a 10X stock, 25 μL of 10X PBS was added and the 
final volume was adjusted with water. Reaction volumes varied from 500 μL to 250 
μL depending on protein yields.  At completion, reactions were quenched with 
ammonium chloride and diluted with an equal volume of ethyl acetate.  Trans-beta 
nitro styrene (internal standard) was added to 5 mM from a 100X stock in DMSO. 
The reaction was transferred to an Eppendorf tube and vortexed.  The reaction was 
then centrifuged at 15000 rpm for 1 minute.  The organic layer was injected into 
Agilent LC 1260 Infinity II system equipped with an Astec Chirobiotic V2 10cm * 4.6 
mm, 5μM column.  An isocratic 80:20 hexanes:isopropyl alcohol premixed solvent 
system at 1.00ml/min with detection at 254 nm was used. Peaks corresponding to 
product and internal standard were integrated to obtain yields.   
2.4.11 Reductive amination 
 Protein, or control molecule was dilute to working concentration (10-100 µM) 
in 200 mM phosphate buffer, pH 7.4 in an Agilent screw top clear glass vial 
equipped with a stir bar. Ketone or aldehyde substrate was added from a 50X stock 
in acetonitrile to final concentration between 1 and 100 mM. The mixture was 
allowed to stir at room temperature for 30 minutes.  Sodium cyanoborohydride was 
added to 25 mM from a 10X stock in water. The reaction was stirred for an additional 
hour.  The reaction was then pipetted into an Amicon Ultra-10 centrifugal filters 
(EMD Milipore). The reaction was diluted with phosphate buffer to 15 ml and 
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centrifuged to 500 μL at 4500 rpm.  This wash was repeated three times. The protein 
was then passed through a 0.22-μm filter and then carried on to mass spectrometry 
analysis. 
2.5 Supporting Information 
2.5.1 Protein and DNA sequences 
sfGFP14TAG DNA sequence: 
ATGGTTAGCAAAGGTGAAGAACTGTTTACCGGCGTTGTGCCGATTCTGGTGGA
ACTGGATGGTGATGTGAATGGCCATAAATTTAGCGTTCGTGGCGAAGGCGAAG
GTGATGCGACCAACGGTAAACTGACCCTGAAATTTATTTGCACCACCGGTAAAC
TGCCGGTTCCGTGGCCGACCCTGGTGACCACCCTGACCTATGGCGTTCAGTGC
TTTAGCCGCTATCCGGATCATATGAAACGCCATGATTTCTTTAAAAGCGCGATG
CCGGAAGGCTATGTGCAGGAACGTACCATTAGCTTCAAAGATGATGGCACCTA
TAAAACCCGTGCGGAAGTTAAATTTGAAGGCGATACCCTGGTGAACCGCATTG
AACTGAAAGGTATTGATTTTAAAGAAGATGGCAACATTCTGGGTCATAAACTGG
AATATAATTTCAACAGCCATTAGGTGTATATTACCGCCGATAAACAGAAAAATGG
CATCAAAGCGAACTTTAAAATCCGTCACAACGTGGAAGATGGTAGCGTGCAGC
TGGCGGATCATTATCAGCAGAATACCCCGATTGGTGATGGCCCGGTGCTGCTG
CCGGATAATCATTATCTGAGCACCCAGAGCGTTCTGAGCAAAGATCCGAATGAA
AAACGTGATCATATGGTGCTGCTGGAATTTGTTACCGCCGCGGGCATTACCCA
CGGTATGGATGAACTGTATAAAGGCAGCCACCATCATCATCACCATTAA 
sfGFP149TAG protein sequence: 
M V S K G E E L F T G V V P I L V E L D G D V N G H K F S V R G E G E G D A T 
N G K L T L K F I C T T G K L P V P W P T L V T T L T Y G V Q C F S R Y P D H M 
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K R H D F F K S A M P E G Y V Q E R T I S F K D D G T Y K T R A E V K F E G D 
T L V N R I E L K G I D F K E D G N I L G H K L E Y N F N S H N V Y I T A D K Q K 
N G I K A N F K I R H N V E D G S V Q L A D H Y Q Q N T P I G D G P V L L P D N 
H Y L S T Q S V L S K D P N E K R D H M V L L E F V T A A G I T H G M D E L Y K 
G S H H H H H H  
DERA DNA sequence: 
ATGGATCTGGCAGCCCATATTGATCATACCCTGCTGAAACCGACCGCAACCCT
GGAAGAAGTTGCAAAAGCAGCCGAAGAGGCACTGGAATATGGTTTTTATGGTC
TGTGTATTCCGCCTAGCTATGTTGCATGGGTTCGTGCACGTTATCCGCATGCAC
CGTTTCGTCTGGTTACCGTTGTTGGTTTTCCGCTGGGTTATCAAGAAAAAGAAG
TTAAAGCACTGGAAGCAGCACTGGCATGTGCACGTGGTGCAGATGAAGTTGAT
ATGGTTCTGCATCTGGGTCGTGCAAAAGCCGGTGATCTGGATTATCTGGAAGC
CGAAGTTCGTGCAGTTCGTGAAGCAGTTCCGCAGGCAGTTCTGAAAGTTATTCT
GGAAACCGGTTATTTTAGTCCGGAAGAAATTGCACGTCTGGCCGAAGCAGCAA
TTCGTGGTGGTGCCGATTTTCTGAAAACCAGCACCGGTTTTGGTCCGCGTGGT
GCCAGCCTGGAAGATGTGGCACTGCTGGTTCGTGTTGCACAGGGTCGTGCCC
AGGTTAAAGCAGCGGGTGGTATTCGTGATCGTGAAACCGCACTGCGTATGCTG
AAAGCGGGTGCAAGCCGTCTGGGCACCAGCAGCGGTGTTGCACTGGTTGCCG
GTGAAGGTGGCACCCTGGGCTATCTCGAGCACCACCACCACCACCACTGA 
DERA protein sequence: 
M D L A A H I D H T L L K P T A T L E E V A K A A E E A L E Y G F Y G L C I P P S 
Y V A W V R A R Y P H A P F R L V T V V G F P L G Y Q E K E V K A L E A A L A 
C A R G A D E V D M V L H L G R A K A G D L D Y L E A E V R A V R E A V P Q A 
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V L K V I L E T G Y F S P E E I A R L A E A A I R G G A D F L K T S T G F G P R G 
A S L E D V A L L V R V A Q G R A Q V K A A G G I R D R E T A L R M L K A G A 
S R L G T S S G V A L V A G E G G T L G Y L E H H H H H H  
IGPS DNA sequence: 
ATGCGTCCGGATCTGAGCCGTGTTCCGGGTGTTCTGGGTGAAATTGCACGTAA
ACGTGCCAGCGAAGTTGCACCGTATCCGCTGCCGGAACCGCCTAGCGTTCCG
AGCTTTAAAGAAGCACTGCTGCGTCCTGGTCTGAGTGTTATTGCAGAAGTTAAA
CGTCAGAGCCCGAGCGAAGGTCTGATTCGTGAAGTTGATCCGGTTGAAGCAGC
ACTGGCCTATGCACGTGGTGGTGCACGTGCCGTTAGCGTTCTGACCGAACCGC
ATCGTTTTGGTGGTAGCCTGCTGGATCTGAAACGTGTTCGTGAAGCAGTTGATC
TGCCGCTGCTGCGTAAAGATTTTGTTGTTGATCCGTTTATGCTGGAAGAGGCAC
GTGCGTTTGGTGCAAGCGCAGCCCTGCTGATTGTTGCACTGCTGGGTGAACTG
ACCGGTGCATATCTGGAAGAAGCCCGTCGTCTGGGTCTGGAAGCACTGGTTGA
AGTTCATACCGAACGTGAACTGGAAATTGCCCTGGAAGCCGGTGCCGAAGTTC
TGGGTATTAACAATCGTGATCTGGCAACCCTGCATATTAATCTGGAAACCGCAC
CTCGCCTGGGTCGTCTGGCACGCAAACGTGGTTTTGGCGGTGTGCTGGTTGCA
GAAAGCGGTTATAGCCGTAAAGAAGAACTGAAAGCACTGGAAGGTCTGTTTGA
TGCAGTTCTGATTGGCACCAGCCTGATGCGTGCACCGGATCTGGAAGCTGCAC
TGCGCGAACTGGTTGGCCTCGAGCACCACCACCACCACCACTGA 
IGPS protein sequence:  
M R P D L S R V P G V L G E I A R K R A S E V A P Y P L P E P P S V P S F K E A 
L L R P G L S V I A E V K R Q S P S E G L I R E V D P V E A A L A Y A R G G A R 
A V S V L T E P H R F G G S L L D L K R V R E A V D L P L L R K D F V V D P F M 
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L E E A R A F G A S A A L L I V A L L G E L T G A Y L E E A R R L G L E A L V E V 
H T E R E L E I A L E A G A E V L G I N N R D L A T L H I N L E T A P R L G R L A 
R K R G F G G V L V A E S G Y S R K E E L K A L E G L F D A V L I G T S L M R A 
P D L E A A L R E L V G L E H H H H H H  
MbPylRS DNA sequence: 
ATGATGGATAAAAAACCGCTGGATGTGCTGATTAGCGCGACCGGCCTGTGGAT
GAGCCGTACCGGCACCCTGCATAAAATCAAACATCATGAAGTGAGCCGCAGCA
AAATCTATATTGAAATGGCGTGCGGCGATCATCTGGTGGTGAACAACAGCCGT
AGCTGCCGTACCGCGCGTGCGTTTCGTCATCATAAATACCGCAAAACCTGCAA
ACGTTGCCGTGTGAGCGATGAAGATATCAACAACTTTCTGACCCGTAGCACCG
AAAGCAAAAACAGCGTGAAAGTGCGTGTGGTGAGCGCGCCGAAAGTGAAAAAA
GCGATGCCGAAAAGCGTGAGCCGTGCGCCGAAACCGCTGGAAAATAGCGTGA
GCGCGAAAGCGAGCACCAACACCAGCCGTAGCGTTCCGAGCCCGGCGAAAAG
CACCCCGAACAGCAGCGTTCCGGCGTCTGCGCCGGCACCGAGCCTGACCCGC
AGCCAGCTGGATCGTGTGGAAGCGCTGCTGTCTCCGGAAGATAAAATTAGCCT
GAACATGGCGAAACCGTTTCGTGAACTGGAACCGGAACTGGTGACCCGTCGTA
AAAACGATTTTCAGCGCCTGTATACCAACGATCGTGAAGATTATCTGGGCAAAC
TGGAACGTGATATCACCAAATTTTTTGTGGATCGCGGCTTTCTGGAAATTAAAA
GCCCGATTCTGATTCCGGCGGAATATGTGGAACGTATGGGCATTAACAACGAC
ACCGAACTGAGCAAACAAATTTTCCGCGTGGATAAAAACCTGTGCCTGCGTCC
GATGCTGGCCCCGACCCTGTATAACTATCTGCGTAAACTGGATCGTATTCTGCC
GGGTCCGATCAAAATTTTTGAAGTGGGCCCGTGCTATCGCAAAGAAAGCGATG
GCAAAGAACACCTGGAAGAATTCACCATGGTTAACTTTTGCCAAATGGGCAGC
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GGCTGCACCCGTGAAAACCTGGAAGCGCTGATCAAAGAATTCCTGGATTATCT
GGAAATCGACTTCGAAATTGTGGGCGATAGCTGCATGGTGTATGGCGATACCC
TGGATATTATGCATGGCGATCTGGAACTGAGCAGCGCGGTGGTGGGTCCGGTT
AGCCTGGATCGTGAATGGGGCATTGATAAACCGTGGATTGGCGCGGGTTTTGG
CCTGGAACGTCTGCTGAAAGTGATGCATGGCTTCAAAAACATTAAACGTGCGA
GCCGTAGCGAAAGCTACTATAACGGCATTAGCACGAACCTGTAA 
MbPylRS protein sequence:  
M M D K K P L D V L I S A T G L W M S R T G T L H K I K H H E V S R S K I Y I E 
M A C G D H L V V N N S R S C R T A R A F R H H K Y R K T C K R C R V S D E 
D I N N F L T R S T E S K N S V K V R V V S A P K V K K A MP K S V S R A P K P 
L E N S V S A K A S T N T S R S V P S P A K S T P N S S V P A S A P A P S L T R 
S Q L D R V E A L L S P E D K I S L N M A K P F R E L E P E L V T R R K N D F Q 
R L Y T N D R E D Y L G K L E R D I T K F F V D R G F L E I K S P I L I P A E Y V 
E R M G I N N D T E L S K Q I F R V D K N L C L R P M L A P T L Y N Y L R K L D 
R I L P G P I K I F E V G P C Y R K E S D G K E H L E E F T M V N F C Q M G S G 
C T R E N L E A L I K E F L D Y L E I D F E I V G D S C M V Y G D T L D I M H G D 
L E L S S A V V G P V S L D R E W G I D K P W I G A G F G L E R L L K V M H G 
F K N I K R A S R S E S Y Y N G I S T N L  
2.5.2 Primer Sequences 
DERA_Nde1_F:  
GTGGTGCATATGGACCTGGCCGCCCACA 
DERA_Xho1_R:  
GTGGTGCTCGAGGTAGCCAAGGGTCCCC 
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IGPS_NdeI_F:  
GCGGACCATATGCGTCCGGATCTGAGCCG 
IGPS_XhoI_R:  
GCGGACCTCGAGGCCAACCAGTTCGCGCAGTGC 
DERA_NcoI_F:  
GCGCACCCATGGATCTGGCAGCCCATATTG 
HisTag_PmeI_R:  
GTGGACGTTTAAACTCAGTGGTGGTGGTGGTGG 
NcoI_tHisF_F:  
GCGGACCCATGGGCCTGGCCAAACGTATTATTGC 
DERA_K151_TAG_F: 
GATGTTGGTCTCATCTGTAGACCAGCACCGGTTTTGGTCCGC 
DERA_K151_TAG_R: 
GATGTTGGTCTCACAGAAAATCGGCACCACCACGAATTGC 
DERA_K151_Ala_F: 
GATGTTGGTCTCATCTGGCTACCAGCACCGGTTTTGGTCCGC 
DERA_K180_TAG_F: 
GATGTTGGTCTCAGGTTTAGGCAGCGGGTGGTATTCGTGATCG 
DERA_K180_TAG_R: 
GATGTTGGTCTCAAACCTGGGCACGACCCTGTGCAACACG 
DERA_K180_Ala_F: 
GATGTTGGTCTCAGGTTGCTGCAGCGGGTGGTATTCGTGATCG 
tHisF_N22_TAG_F:  
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GCAGCGGGTCTCACACCTAGTTTGAAAATCTGCGTG 
tHisF_N22_TAG_R:  
GCAGCGGGTCTCAGGTGCCTTTAACAACACG 
tHisF_E24_TAG_F:  
GCAGCGGGTCTCACTTTTAGAATCTGCGTGATAGC 
tHisF_E24_TAG_R:  
GCAGCGGGTCTCAAAAGTTGGTGCCTTTAAC 
tHisF_R27_TAG_F:  
GATGTTGGTCTCATCTGTAGGATAGCGGTATC 
tHisF_R27_TAG_R:  
GATGTTGGTCTCACAGATTTTCAAAGTTGGTGC 
tHisF_L50_TAG_F:  
GATGTTGGTCTCAGTTTTAGGATATCACCGCAAGCGTTG 
tHisF_L50_TAG_R:  
GATGTTGGTCTCAAAACACCAGCTCATCAATGCCAATTTC 
tHisF_T78_TAG_F:  
GATGTTGGTCTCTGTTTTAGGTTGGTGGTGGCATCCATG 
tHisF_T78_TAG_R:  
GATGTTGGTCTCTAAACGGAATATCAATCTGCTCTG 
tHisF_L169_TAG_F:  
GATGTTGGTCTCTAATTTAGCTGACCAGCATTGATCGTG  
tHisF_L169_TAG_R:  
GATGTTGGTCTCTAATTTCACCGGCACCACG 
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tHisF_T171_TAG_F:  
GATGTTGGTCTCAGCTGTAGAGCATTGATCGTGATGGC 
tHisF_T171_TAG_R:  
GATGTTGGTCTCACAGCAGAATTTCACCGGCACCAC 
2.5.3 Small molecule synthesis and characterization 
 All reagents were obtained from commercial suppliers and used without 
further purification. N-Boc-D-proline, N⍺-Boc-L-Lysine, (S)-N-Boc-3-
hydroxypyrrolidine, (R)-N-Boc-3-hydroxyproline,3-(3-Dimethylaminoproply)-1-ethyl-
carbodimide hydrochloride (EDC•HCl), N,N’-Disuccinimidyl carbonate, 4-Amino-L-
phenylalanine, 1-Hydroxybenzotriazole hydrate (HOBt), N,N'-
Dicyclohexylcarbodiimide (DCC) were obtained from Chem-Impex. 4-
Dimethylaminopyridine (DMAP), anhydrous dichloromethane (DCM), and N-N-
Dimethylformamide (DMF) “extra dry acro sealed” were obtained from Acros 
Organics. Lastly, N-hydroxysuccinimide, hydrogen chloride solution, 4 M in dioxane, 
anhydrous 1-4 dioxane and 9-Borabicyclo[3.3.1]nonane solution, 0.5 M in THF (9-
BBN) and N,N-Diisopropylethylamine (DIPEA), 4-nitrobenzaldehyde, trans-beta-
nitrostyrene and acetone were obtained from Sigma Aldrich. All anhydrous and extra 
dry reagents were sparged with N2 or Ar prior to use.  
N6-(D-prolyl)-4-Amino-L-phenylalanine, Pro4AF 
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Compound 1a, 4-Amino-L-phenylalanine was dissolved in anhydrous methanol (1 
mmol) then 9-BBN in THF (1.5 mmol) was added. The solution was stirred overnight.  
The reaction was diluted with ethyl acetate, workup with brine and the organic layer 
was dried over sodium sulfate.  The crude reaction was concentrated and then dilute 
with minimal ethyl acetate to dissolve crude product.  This was passed over silica 
and the product was eluted with a 20-80% gradient ethyl acetate/hexanes. (70%) 
 
 Compound 1b, Boc-D-proline (1mmol) and HOBt (1 mmol) was dissolved in ethyl 
acetate (0.2 M) in an ice bath.  DCC (1.4 mmol) was added and the mixture was 
stirred until precipitation of dicyclohexylurea (DCU), ~30mins.  The mixture was 
filtered to remove DCU. Compound 1a and DIPEA (1 mmol) was added and the 
reaction was stirred overnight. A white precipitant was collected by filtration.  This 
NH2
H2N
O
OH
9-BBN
MeOH
reflux
NH2
HN
O
O
B-
compound 1a
N
O
OH
Boc
NH2
HN
O
O
B-
+
HOBT
DCC
DIPEA
EtOAc
NH
HN
O
O
B-
ON
Boc
compound 1b
 85 
crude product, containing small amounts of DCU was carried out without further 
purification. (75%).  
 
Compound 1c, Crude compound 1b was dissolved in THF (0.01 M). 14 equivalences 
of ethylene diamine was added dropwise.  A solid precipitated.  The reaction was 
stirred overnight and the precipitated solid was collected by filtration.  This crude 
product was taken on without further purification.  
 
 Compound 1, Crude compound 1c was dissolved in 4 M HCL in dioxane (12 eq. of 
HCL) and stirred overnight.  A white precipitant was collected by filtration.  This was 
dissolved in water and purified by reverse phase chromatography by a 5 to 95% 
water/acetonitrile gradient. Pure amino acid eluted immediately from the column. 
(quantitative) Calculated mass: m/z [M+H] = 278.1499 observed mass: m/z [M+H] = 
278.1504  
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1H NMR (400 MHz, D2O) δ 11.2 (s, 1H), 10.26 (s, 1H), 8.86 (s, 1H), 7.62 (d, 2H), 
7.26 (d, 2H), 4.42 (t, 1H), 4.11 (q, 1H), 3.12 (t, 3H), 2.51 (m, 2H), 2.44 (m, 1H), 1.94 
(m, 3H). 
N6-(D-prolyl)-L-Lysine, ProK 
 
Compound 2a, N-Boc-D-proline, (1 mmol) was dissolved in anhydrous 
dichloromethane (0.2 M). EDC HCl (1.3 mmol) and DMAP (0.8mmol) were added 
slowly in an ice bath. The solution was stirred until a color change to yellow/orange 
was observed. N-hydroxysuccinimide (1.3 mmol) was then added and the water bath 
was removed. The reaction was stirred overnight. The orange solution with brine and 
dichloromethane. The DCM layer was dried using sodium sulfate and concentrated 
to give an orange solid. The product was then purified using flash column 
chromatography 20-80% ethyl acetate/hexanes gradient.  The product was a while 
powder (80%).  
 
Compound 2b, N⍺-Boc-L-Lysine (1.3 mmol) was dissolved in DMF (0.2 M). 
Compound 2a was added to the solution (1 mmol). The reaction was stirred 
overnight and then diluted with water and ethyl acetate. Remaining N⍺-Boc-L-Lysine 
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is soluble in the water layer. The ethyl acetate layer was concentrated in vacuo to 
give compound 2b as an oil (82%).  
 
Compound 2, D-ProK, Compound 2b was dissolved in 4 M HCl in dioxane (9 eq. 
HCl) and stirred overnight. The reaction was diluted to in water and ethylacetate. 
The product was soluble in water and compound 2b in ethylacetate. The water 
solution was then concentrated in vacuo yielding D-ProK, in the form of a yellow 
viscous oil (¬¬¬-quantitative). Calculated mass: m/z [M+H] = 244.1656, observed 
mass: m/z [M+H] = 244.1669  
1H NMR (400 MHz, DMSO- D6) δ 4.38-4.19 (m, 1H), 4.12-3.94 (m, 1H), 3.49-3.26 
(m, 2H), 3.26-3.06 (m, 2H), 2.49-2.26 (m, 1H), 2.17-1.73 (m, 5H), 1.64-1.45 (m, 2H), 
1.45-1.24 (m, 2H).  
N6-((pyrrolidin-3-yloxy)carbonyl)-L-lysine, (R) and (S) PyrrolK 
 
 Compound 3a, (S)-N-Boc-3-hydroxypyrrolidine and (R)-N-Boc-3-hydroxyproline 
were carried through the synthesis separately to yield (R)-PyrrolK and (S)-PyrrolK.  
A solution of N-Boc-3-hydroxypyrrolidine (1 mmol), N,N’-Disuccinimidyl carbonate 
(1.5 mmol) and trimethylamine (2 mmol) in anhydrous acetonitrile (0.2 M) was stirred 
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at room temperature overnight.  The reaction was diluted with saturated sodium 
bicarbonate and ethyl acetate.  The organic layer was washed with brine and dried 
over magnesium sulfate.  The organic layer concentrated to a yellow oil. The crude 
organic extract was purified by normal phase chromatography by a 20 to 80% 
gradient, ethyl acetate/hexanes. (20%)  Calculated mass: m/z [M+Na] = 351.1192, 
observed mass: m/z [M+Na] = 351.1195  
 
Compound 3b, Purified compounds 3a (1mmol) was dissolved in DMF (0.2 M).  N⍺-
Boc-L-lysine (1.3 mmol) was added and the reaction was stirred overnight.  The 
reaction was diluted with DCM and water. The DCM layer was washed with water 
and dried over sodium sulfate.  The organic extract concentrated to a yellow/brown 
oil. The oil was purified using reverse phase chromatography with a gradient of 5 to 
95 % water/acetonitrile. (quantitative) Calculated mass: m/z [M+Na] = 482.2492, 
observed mass: m/z [M+Na] = 482.2459  
 
Compound 3, (R)-PyrrolK and (S)-PyrrolK, Compound 3b was dissolved in 4 M HCL 
in dioxane (35 eq. of HCl). A solid precipitated as the reaction stirred overnight. The 
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dioxane was removed by vacuum. The sticky solid was dissolved in water and 
purified by reverse phase chromatography by a 5 to 95% water/acetonitrile gradient. 
(quantitative) Pure amino acid eluted immediately from the column. Calculated 
mass: m/z [M+H] = 260.1573, observed mass: m/z [M+H] = 260.1611 
2.5.4 1H NMR 
Pro4AF 
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 ProK 
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CHAPTER 3: 19F NMR INVESTIGATION OF PROTEIN AND PROTEIN COMPLEX 
STABILITY VIA UNNATURAL AMINO ACID MUTAGENESIS1 
  
3.1 Introduction 
 Life evolved in water. Accordingly, cellular survival required a mechanism to 
cope with fluctuations in external osmolality. Natural selection arrived at a simple 
solution; the accumulation or depletion of small molecules called osmolytes (113). 
Osmolytes are compatible solutes because they do not perturb macromolecular 
structure and function (113). The thermodynamic origin of compatibility as it applies 
to protein tertiary structure was elucidated through application of transfer free 
energies and the Tanford transfer model (114-116). This model suggests that 
osmolytes are preferentially excluded from protein backbone, and thus favor the 
folded state by decreasing the conformational entropy of the unfolded ensemble, 
although the idea remains controversial (117, 118). No matter the mechanism, 
osmolytes stabilize native protein folds and counteract the destabilizing forces 
arising from augmented intracellular crowding during osmotic stress (119) or the 
accumulation of urea (120). This stabilization has been the primary emphasis in 
discussions of osmolyte fitness. Proteins, however, do not function in isolation, and 
focusing solely on protein folding equilibria may provide an incomplete picture of the 
specialized ability of osmolytes to serve as compatible solutes. 
                                            
1 Figures and data described in this chapter have been submitted accompanying a similar 
narrative as a communication to the Journal of the American Chemical Society.    
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Protein-protein interactions are ubiquitous; for example, the interactome of 
human cells encompasses at least 5,400 proteins communicating via 28,500 
interactions (121). Despite the fundamental role of protein surfaces, the influence of 
osmolytes on protein interfaces has garnered limited attention (122-129). In general, 
osmolytes that stabilize protein folds tend to stabilize protein complexes but there 
are exceptions (129). In addition, the transfer model, which accurately predicts 
osmolyte influence on folding equilibria, does not address effects on protein-protein 
interactions. This shortcoming has been rationalized in terms of differences in the 
interactions that drive folding and protein-complex assembly. Whereas protein folds 
are stabilized to a large extent by backbone hydrogen bonds localized in elements of 
secondary structure (130), protein interfaces are predominately composed of side 
chain interactions with less emphasis on backbone interactions (131, 132).  
Recent studies have broadened our appreciation of the importance of protein 
surfaces. These studies emphasize that, in addition to supporting solubility and 
contact with water, electrostatic interactions of surface residues also contribute to 
protein stability (133). The physiological implications of these interactions, which are 
destabilizing if attractive and stabilizing if repulsive, have been demonstrated in the 
crowded interior of Escherichia coli cells (134-137) and under in vitro cell-like 
conditions (138, 139). During osmotic stress, electrostatic interactions between 
macromolecules are predicted to be intensified due to the efflux of cytosolic water 
and consequent increase in macromolecular crowding (119, 140, 141). In light of the 
known behavior of osmolytes as compatible solutes with respect to the stability of 
protein tertiary structure, we hypothesized that the molecules selected for 
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accumulation during stress must also be compatible with the interactions of protein 
surfaces.  
Here, we evaluate the effect of a panel of cosolutes, including osmolytes and 
related non-osmolyte biomolecules, on the stability of a model protein (the SH3 
domain of the Drosophila signal transduction protein drk) and a protein complex [the 
side-by-side symmetric homodimer of the B1 domain of the streptococcal 
immunoglobulin binding protein G, (GB1)]. Determination of protein and protein 
complex stability was facilitated by incorporating an unnatural amino acid bearing a 
trifluoromethyl probe that allowed simple quantification of protein populations via 19F 
NMR. With the exception of urea, osmolytes and non-osmolytes stabilize the fold of 
SH3. Divergent behavior was observed for the protein-protein interaction; osmolytes 
had a benign influence on oligomerization, whereas non-osmolytes favored the 
dimer. These results suggest compatibility with both protein structure and protein-
protein interactions are important features of osmolytes. 
3.2 Results 
3.2.1 Cosolute selection  
 We selected a panel of fourteen molecules (SI Appendix, Fig. S1) that have 
historically been categorized as osmolytes and encompass the diverse chemical 
structures utilized by various organisms. These molecules include amino acids and 
their derivatives (alanine, β-alanine, glutamate, glycine, proline and taurine), 
methylamines (betaine, sarcosine, trimethylamine-N-oxide), polyols (glycerol, 
trehalose, sorbitol, sucrose), and urea (a denaturing osmolyte). For comparison, we 
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chose eight molecules that are also critical for cellular function but are not 
osmolytes, including other amino acids (arginine, glutamine, and lysine), prominent 
intracellular cations (polyamines and sodium) and anions (acetate and citrate). 
Notably, the majority of these osmolytes and non-osmolytes are also employed as 
additives in formulations of protein therapeutics in order to extend shelf life and/or 
prevent aggregation (142).  
3.2.2 Model Proteins 
 To investigate cosolute induced changes in protein stability, we chose the N-
terminal SH3 domain of the Drosophila signal transduction protein drk, SH3. SH3 is 
meta stable with a dynamic equilibrium between the folded and unfolded populations 
and has served as a model system for protein folding investigations, including 19F 
NMR experiments. Importantly, SH3 is destabilized in cells in response to osmotic 
stress, and the destabilization is alleviated by adding the osmolyte betaine (119, 
137).  
As a protein complex, we chose the B1 domain of the streptococcal 
immunoglobulin binding protein G (GB1). Wild type GB1 is monomeric, however, a 
single hydrophobic mutation, A34F, induces a side-by-side symmetric homodimer 
(143) that serves as a model system to examine protein oligomer stability (41). The 
stability of the dimer varies with weak attractive or repulsive surface electrostatic 
interactions, such as those that may accumulate during osmotic stress (144). 
Furthermore, the dissociation constant, 𝐾/, of the GB1 dimer, >1	𝜇M, is in the range 
of the transient protein-protein interactions that organize and regulate cells (134, 
145). SH3 and GB1 are both acidic with pI values of 4.6 and 4.5, respectively, which 
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is representative of the majority of proteins in Escherichia coli and Bacillus subtilis 
(146, 147).  
3.2.3 Quantifying Unfolding and Dimerization 
 19F NMR was employed to measure the free energies of SH3 unfolding 
(∆𝐺2→3°1 ) and GB1 dimer dissociation (∆𝐺/→0°1 ). Fluorine is a convenient nucleus 
because19F is 100% naturally abundant, rarely used in biology and 19F NMR 
chemical shifts are sensitive to the local chemical environment (31). As the probe, 
we made use of a genetically encoded unnatural amino acid, 4-(trifluoromethyl)-L-
Phenylalanine (TFMF, Fig. 1A Inset), which has been used for in-cell NMR (31, 148).  
For SH3, TFMF was introduced in place of Tyr37 (SI Appendix Fig. S2), 
which is buried in the folded protein. The 19F NMR spectra of SH3-Y37TFMF exhibits 
two resonances, one from the folded state at 61.96 ppm and the other from the 
unfolded ensemble at 61.80 ppm, (Fig. 1A). TFMF minimally impacts SH3 stability, 
reducing the midpoint temperature of denaturation in buffer from 36 °C to 32 °C (SI 
Appendix, Fig S3).  
For GB1, we hypothesized that incorporation of TFMF (a Phe analog) in place 
of A34 (SI Appendix Fig. S2) would induce dimerization in a similar fashion to A34F 
and provide a probe of dimer formation (143). 15N-1H heteronuclear single quantum 
correlation (HSQC) spectra of the GB1-A34TFMF closely match spectra of GB1-
A34F (SI Appendix Fig. S4) suggesting dimer formation is promoted and the overall 
structure is maintained. Small changes in shifts are observed for residues lining the 
hydrophobic dimer interface and are likely due to the increased size of the TFMF 
side chain with respect to Phe. These disruptions are reflected by a 𝐾/ (440 
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±	10	𝜇M) 7.5-times greater than the value for the A34F variant (41). The 19F spectra 
of GB1-A34TFMF exhibits two concentration-dependent resonances (Figure 1B) 
indicative of the monomer (-61.90 ppm) and dimer (-62.05 ppm) populations.  
 
Figure 3.1 Quantification of protein- and dimer-stability by 19F NMR  
(A) TFMF-labeled SH3 displays resonances corresponding to the folded state (F) and the unfolded 
ensemble (U) at 298 K, pH 7.4. Inset: Structure of 4-(trifluoromethyl)-L-Phenylalanine (TFMF). (B) 
TFMF-labeled GB1 shows concentration-dependent dimer (D) and monomer (M) resonances at 298 
K, pH 7.4.  
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 SH3-Y37TFMF and GB1-A34TFMF stability in the presence of cosolutes 
were quantified as described in Materials and Methods. Changes in stability with 
respect to buffer, ∆∆𝐺2→3°1  and ∆∆𝐺/→0°1  (summarized in SI Appendix Table S1) are 
defined such that increased stability results in a positive value and decreased 
stability is a negative value.  For GB1-A34TFMF,	∆∆𝐺/→0°1  was determined at a 
single concentration, 125 𝜇M. For a subset of cosolutes, ∆∆𝐺/→0°1  values were 
determined from binding isotherms and the results are in agreement with single 
concentration measurements. (SI Appendix Fig. S5 and Table S2).  
 With the exception of urea (a known denaturing osmolyte), all cosolutes 
stabilized SH3 (Fig. 2A). No trend was observed that distinguished osmolytes from 
non-osmolytes and some non-osmolytes (citrate, lysine, and acetate) provided the 
largest enhancements in stability. 𝛥𝛥𝐺/→0°’	  values for GB1 showed more variation 
than 𝛥𝛥𝐺2→3°’	  values of SH3. In addition, differences are observed in the 
performance of osmolytes with respect to non-osmolyte solutes (Fig. 2B). With the 
exception of glycine and glutamate, osmolytes minimally perturbed dimer stability, 
typically increasing 𝛥𝛥𝐺/→0°’	  by less than 1 kcal/mol. On the other hand, all non-
osmolytes under investigation showed a more pronounced (1 – 2 kcal/mol) change 
in 𝛥𝛥𝐺/→0°’	  in favor of dimer formation. Notably, stabilization of the GB1 dimer 
qualitatively trends with the absolute charge of the cosolute, and species with the 
highest overall charge (either positive or negative) induced the greatest stabilization 
of the dimer. 
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Figure 3.2 Osmolytes perturb neither unfolding nor dissociation 
Changes in free energy (∆∆𝐺°1 = 	∆𝐺:;<;=>?@°1 − 	∆𝐺B>CC@D°1 ) for SH3 unfolding (𝛥𝛥𝐺2→3°’	 , panel A) and 
GB1 dissociation (𝛥𝛥𝐺/→0°’	 , panel B) were determined in the presence or absence of 400 mM 
cosolute. Osmolytes are shown in yellow and non-osmolytes are shown in blue. Glutamine was used 
at 200 mM and glutamate at 60 mM because of solubility. Error bars represent the standard deviation 
of the mean from three independent protein preparations. Quantification of 𝛥𝛥𝐺2→3°’	  for SH3 in citrate 
was not possible because there was no resonance from the unfolded form, and is reported as greater 
than the most stabilizing quantifiable cosolute, lysine. 
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3.2.5 Electrostatic contributions to 𝜟𝜟𝑮𝑫→𝑴°’	  
 The stability of monomeric GB1 increases concomitant with increasing pH in 
living E. coli cells (136). This observation can be explained in terms of surface 
charge. GB1 has a net charge of −4 at pH 7.4. As the surface of GB1 transitions 
from anionic to cationic, there are more favorable electrostatic interactions between 
negatively-charged cytosolic E. coli macromolecules and GB1 (149). In addition, 
GB1 dimerization is driven by a hydrophobic interaction that overcomes the self-
repulsion between two like-charged monomers. Given these observations and the 
stabilization of the GB1 dimer in the presence of charged cosolutes, we investigated 
the contribution of electrostatic interactions to dimer stability.  
19F spectra of the GB1 dimer were acquired in buffer between pH 7 and pH 4.  
A shift from predominately monomeric- to predominately dimeric- GB1 was observed 
with decreasing pH (SI Appendix, Fig. S6). In addition, a small amount of a higher-
order aggregate, as characterized by dynamic light scattering (SI Appendix, Fig. S7), 
formed at pH values less than 6. Furthermore, the population of dimer correlates 
positively with the concentration of NaCl (SI Appendix, Fig S8). These data suggest 
that the stability of the GB1 dimer is strongly influenced by electrostatic interactions 
and that Coulombic screening of repulsive charges promotes association. We 
therefore evaluated the effect of a subset of cosolutes, both osmolytes and non-
osmolytes, at a lower pH value where electrostatic repulsion would be minimized 
due to neutralization of acidic surface side chains (see Materials and Methods). At 
pH 4, the 19F spectra indicated mostly (~ 75 %) dimer and higher-order species, 
consistent with the attenuation of repulsive charge-charge interactions. The 
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population of dimer at this pH value was unaffected by adding cosolutes, suggesting 
that these cosolutes have a negligible influence on the equilibrium between dimeric 
and monomeric GB1 (SI Appendix, Fig S9 and Table S3).  
3.3 Discussion 
Osmolytes are traditionally characterized as protein stabilizing agents (150). 
Our data suggest that this characterization is too narrow.  Small molecules, related 
to but not utilized as osmolytes, stabilize SH3 within the range of the least and most 
powerful osmolytes. Stabilization by virtue of preferential exclusion does not 
preclude non-specific interactions with protein surfaces (151). Therefore, we suggest 
that nature selected osmolytes from those intracellular cosolutes that favorably 
impact protein stability, while avoiding interactions with protein surfaces. Comparing 
glycine to alanine and betaine elucidates some subtleties of the structural 
requirements for protein surface compatibility. Adding a methyl side chain to glycine 
to form alanine decreases dimer stabilization by 0.8 kcal/mol, and trimethylation of 
the glycine amine decreases stabilization to an even greater extent. The dipole of 
osmolytes such as proline and TMAO are sterically restricted from interaction with 
protein dipoles, and themselves, by hydrophobic substituents (152). We suggest that 
removing the hydrophobic bulk of alanine or betaine facilitates the interaction of 
glycine with protein surfaces.  
 Glycine and glutamate show disparate influences on GB1 dimer stability 
when compared to other osmolytes. Potassium glutamate is the predominate 
osmolyte of E. coli and Salmonella typhimurium (153). These organisms rapidly 
accumulate potassium from their surroundings in response to osmotic stress and 
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subsequently synthesize glutamate to provide a counter ion. Potassium glutamate is 
subsequently replaced in the cell by other compatible solutes such as trehalose, 
proline or betaine (153). The definition of glycine as an osmolyte seems to arise from 
its high concentrations in the tissues of marine organisms (154, 155), which are 
specialized in their ability to survive in high concentrations of salt. To the best of our 
knowledge, the only other known occurrence of glycine accumulation in response to 
osmotic stress is in early-stage mouse embryos by action of a Na+/Cl--dependent 
glycine transporter, GLYT1 (156). These data suggest that glutamate and glycine 
have specialized roles in specific organisms and that it may not be advantageous to 
classify them as compatible osmolytes. 
Osmolyte effects on enzyme tertiary structure and steady state kinetics (113, 
120, 157) is well characterized and the molecular mechanism of osmolyte-induced 
protein stabilization is known (116, 158, 159). In stark contrast, the influence of 
osmolytes on protein-protein interactions and consequently, protein surfaces, has 
not been established.  Electrostatic interactions are a fundamental component of 
biomolecular interactions. The charge of protein interfaces has been fine-tuned by 
evolution to enhance the orientation, stability, specificity, and rate of association of 
protein-partner recognition in a manner that is specific to the pH associated with 
their subcellular location (160-164). Disrupting these interactions, via pH, salt 
concentration or mutation, affects protein complex stability (165). Analogously, our 
data suggest that osmolytes are ‘compatible’ with protein-protein interactions 
because they minimally impact electrostatic interactions of protein surfaces.  
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Life inherently depends on the distribution and interaction of macromolecules, 
metabolites and ions.  Spitzer, Poolman, McConkey and Srere attribute the 
organization of the cytoplasm to weak, transient electrostatic interactions between 
charged surfaces and metabolites (149, 166, 167).  Moreover, the biological 
importance of protein surfaces has been recently underscored by reports showing 
that attractive electrostatic interactions are destabilizing to protein structure (135-
137, 168). The transient interactions that organize the cellular interior must have 
factored into the selection of osmolytes by nature. Accordingly, in addition to their 
stabilizing influence on protein tertiary structure, the compatibility of osmolytes with 
quaternary and quinary interactions is a critical feature that enables osmolytes to 
maintain and restore cellular integrity, structure and function in response to 
environmental stress. 
3.4 Materials and Methods 
3.4.1 Materials 
 Antibiotics, osmolytes and other cosolutes were used without further 
purification. Preformulated Luria-Bertani and 2xYT media were acquired from Fisher 
Scientific. 4-(trifluoromethyl)-L-Phenylalanine (TFMF) was purchased from Chem-
Impex International. Restriction enzymes were obtained from New England Biolabs. 
pUltra-CNFRS was obtained from Addgene. pH values are direct meter readings, 
uncorrected for the D2O isotope effect. 
3.4.2 Protein 
 Mutagenesis was performed via restriction ligation of BsaI digested PCR 
fragments generated from primers described in the SI Appendix, Supplemental Text. 
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Agilent BL21(DE3)-Gold cells were co-transformed with pET11a-SH3-Y37TAG or -
GB1-T2Q-A34TAG and pUltra-pCNFRS, a plasmid harboring an orthogonal 4-
cyano-L-phenylalanine tRNA synthetase and tRNACUAMjTyr.  The 4-cyano-L-
phenylalanine tRNA synthetase is permissive for TFMF (95). The T2Q variant of 
GB1 was included to prevent proteolytic degradation (165). A single colony was 
used to inoculate 5 mL of LB media containing 100 µg/L ampicillin to maintain pET 
and 50 µg/L streptomycin to maintain pUltra. The culture was grown to saturation 
overnight at 37 °C with shaking (New Brunswick Scientific Innova I26, 225 rpm). The 
next morning, 1 L of 2xYT media, supplemented with 100 µg/L ampicillin and 50 
µg/L streptomycin, was inoculated with the overnight culture.  When the culture 
reached an optical density at 600 nm (OD600) of 0.3, TFMF was added to final 
concentration of 1 mM. Expression was induced at OD600 0.6 by adding isopropyl β-
D-1-thiogalactopyranoside to a final concentration of 1 mM. After 5 h, the cells were 
pelleted for 30 mins at 1000g, the supernatant discard and the pellet stored at -20 
°C. 
The pellet was thawed at room temperature and resuspended in 25 mL of 20 
mM tris, pH 7.5 for GB1 or 50 mM tris, pH 7.5 for SH3, supplemented with a Roche 
cOmplete protease inhibitor tablet.  Cells were sonicated using a Fisher Scientific 
Sonic Dismembrator model 500 for 8 min at 20% amplitude at a 39% duty cycle.  
Lysates were clarified by centrifugation at 27,000g for 1 h and passed through a 
0.22 μm filter. GB1 and SH3 were purified as described (41, 137) and their purity 
confirmed by SDS-PAGE and Q-TOF mass spectrometry. The purified proteins were 
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exchanged into H2O by dialysis, divided into 500 μL aliquots of 500 μM GB1-
A34TFMF or 50 μM SH3-Y37TFMF, lyophilized and stored at -20°C. 
3.4.3 NMR 
 Stock cosolute solutions (1.0 M) were prepared in the corresponding buffers 
(vide infra) and the pH adjusted to 7.4 with HCl or NaOH. For SH3, an aliquot was 
thawed at room temperature and resuspended to 50 μM using 50 mM HEPES, 50 
mM citrate, 50 mM bis tris propane, pH 7.4. NMR samples were prepared by 
combining this stock solution (250 μL) with 200 µL of stock cosolute solution in the 
same buffer and 50 μL of D2O to given a final SH3 concentration of 25 μM. 
Experiments were performed in triplicate. Spectra were acquired at 298 K on a 
Bruker Avance III HD spectrometer at a 19F Larmor frequency of 470 MHz with a 
cryogenic QCI probe and an H/F channel. The free energy of unfolding (𝛥𝐺2→3;1 ) was 
determined using the following equation,  𝛥𝐺2→3;1 = 	−𝑅𝑇𝑙𝑛(32). 
where U and F are the areas of the corresponding resonances, R is the gas constant 
and T is the absolute temperature.  
Aliquots of GB1 were thawed at room temperature and diluted to 250 μM with 
20 mM Na2HPO4/NaH2PO4, pH 7.4. NMR samples were prepared by combinding 
this stock solution with 200 µL of the 1.0 M cosolute solution in the same buffer and 
50 μL of D2O added for a final GB1 concentration of 125 μM. ∆𝐺/→0°1 , was 
determined, in triplicate, by using the equation,  
∆𝐺/→0°1 = 	−𝑅𝑇𝑙𝑛(2𝑃Q𝐹0S𝐹/ ) 
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where 𝐹0 and 𝐹/, the fractions of monomer and dimer, respectively, were calculated 
from the areas of the corresponding resonances, and 𝑃Q, the total protein 
concentration, was 125 μM.  
For a subset of co-solutes, the dissociation constant, 𝐾/T<, was also obtained by 
serial dilution of a 500 µM sample at five concentrations with and without cosolute, in 
triplicate, and the data fit to the following equation 
𝐹/ = 	4𝑃Q +	𝐾/T< −	 𝐾/S + 8𝑃Q𝐾/T<4𝑃Q  
using MATLAB version R2014b. ∆𝐺/→0°1 for these experiments was calculated using 
the equation, ∆𝐺/→0°1 = −𝑅𝑇𝑙𝑛 𝐾/T< . 
Samples for the pH dependence experiments were prepared as described above, 
but protein and cosolute were resuspended in 50 mM HEPES, 50 mM citrate, 50 mM 
bis-tris propane buffer with and without cosolute and adjusted to the desired pH 
using HCl. The fraction of dimer plus aggregate was determined by summing the 
areas of the dimer and aggregate resonances and dividing by the sum of the areas 
of the dimer, aggregate and monomer resonances.  
3.5 Supporting Information 
3.5.1 Supplementary Text 
Primers for BsaI mutagenesis 
GB1-T2Q-A34TAG F:  
GATGTTGGTCTCAGTACTAGAACGACAACGGTGTTG 
GB1-T2Q-A34TAG R:  
GATGTTGGTCTCAGTACTGTTTGAAAACTTTTTCCGCG 
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GB1-T2Q-TAA STOP F: 
GATGTTGGTCTCACGAATAAGATCCGGCTGCTAAC 
GB1-T2Q-TAA STOP R: 
GATGTTGGTCTCATTCGGTTACCGTGAAGG 
Overhangs are italicized, BsaI cut sites are bold and codon mutations introduced are 
red.  
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3.5.2 Supplementary Tables 
Table S1 Cosolute induced changes in SH3 and GB1 stability (298 K, pH 7.4) 
cosolute  
(400 mM)a 
∆∆G%→'°1  (kcal/mol) 
GB1-A34TFMF 
∆∆GX→Y°1  (kcal/mol) 
SH3-Y37TFMF 
citrate 2.2±0.1 NAd 
spermine 1.94 ± 0.06  0.46 ± 0.05 
spermidine 1.82 ± 0.07 0.32 ± 0.03 
acetate 1.58±0.04 0.62±0.05 
NaCl 1.58 ± 0.02 0.33 ± 0.05 
lysine 1.48 ± 0.05 0.64 ± 0.04 
arginine 1.47 ± 0.06 0.06 ± 0.01 
Glutamateb 1.40±0.09 0.21±0.04 
Glutaminec 1.27 ± 0.04 0.24 ± 0.03 
glycine 1.08 ± 0.03 0.52 ± 0.02 
taurine 0.64 ± 0.04 0.54 ±0.03 
TMAO 0.4 ± 0.1 0.46 ± 0.02 
alanine 0.28 ± 0.03 0.50 ± 0.04 
trehalose 0.26 ± 0.06 0.45 ± 0.05 
β-alanine 0.24 ± 0.04 0.54 ± 0.03 
sarcosine 0.24 ± 0.03 0.45 ± 0.02 
betaine 0.13 ± 0.05 0.21 ± 0.06 
proline 0.02 ± 0.07 0.31 ±0.02 
sorbitol -0.07 ± 0.03 0.42 ± 0.03 
sucrose -0.08 ± 0.04 0.38 ± 0.02 
glycerol -0.10 ± 0.07 0.16 ± 0.03 
urea -0.11 ± 0.02 -0.31 ± 0.04 
 
Footnotes 
a Abbreviations: TMAO, trimethylamine-N-oxide 
bGlutamate was used at 60 mM 
cGlutamine was used at 200 mM 
dNA, not applicable 
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Table S2 GB1-A34TFMF stability from binding isotherms  
cosolutea,b 
(400 mM) 
∆G%→'°1 c 
(kcal/mol) 
K%[\d 
(µM) 
∆∆G%→'°1  
(kcal/mol) 
buffer 4.57±0.01 442±11 NAe 
lysine 6.21±0.04 28±2 1.63±0.04 
TMAO 4.86±0.03 272±15 0.29±0.03 
proline 4.61±0.04 416±29 0.04±0.04 
urea 4.42±0.04 574±39 -0.15±0.04 
Footnotes 
a Abbreviations: TMAO, trimethylamine-N-oxide 
b 298 K, 20 mM KH2PO4/K2HPO4, pH 7.4 
c Error was determined using 1 × 106 iterations of a Monte Carlo analysis using the 
average and standard deviation of each condition 
d Error was assessed using a thousand interactions of a Monte Carlo analysis 
e NA, not applicable 
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Table S3 Cosolute effect on 𝐅𝐃_𝐀 of GB1-A34TFMF pH 4.0. 
cosolutea  
(400 mM) 
F%_a 
TMAO 0.79 ± 0.01 
lysine 0.81 ± 0.02 
proline 0.81 ± 0.02 
urea 0.830 ± 0.005 
trehalose 0.83 ± 0.02 
glycine 0.86 ± 0.02 
buffer (no cosolute) 0.801 ± 0.002 
 
Footnotes 
a Abbreviations: TMAO, trimethylamine-N-oxide 
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3.5.3 Supplementary Figures 
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Figure S2 Selective incorporation of TFMF  
Selective in vivo incorporation of TFMF by 4-cyano-L-phenylalanine synthetase. Expression of SH3-
Y37TFMF (A) and GB1-A34TFMF (B) in the presence (+) and absence of (-) of TFMF over time 
verified by ESI-QToF mass spectrometry. 
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Figure S3 Thermal Stability of SH3 and SH3-Y37TFMF by 19F NMR.  
Stability was measured at 25 µM SH3 (137) and SH3-Y37TFMF in 50 mM HEPES, 50 mM citrate, 50 
mM bis tris propane, pH 7.4. 
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Figure S4 1H-15N HSQC spectrum of GB1-A34TFMF 
Overlay of 1H-15N HSQC spectrum 500 µM GB1-A34TFMF and 500 µM GB1-A34F in 20 mM 
KH2PO4/K2HPO4 buffer, pH 7 at 298 K. Spectra of GB1-A34TFMF, black, is in close agreement with 
spectra of GB1-A34F, red (41). Residues hypothesized to weaken dimer affinity, 8-12, Y33 and F34 
are circled in the A34F spectra. The loop (residues 8-12) that participates in hydrophobic burial of 
Y33, yellow, is shown in gray on GB1 dimer structure. 
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Figure S5 Binding isotherms of GB1-A34TFMF  
GB1 binding isotherms in presence of representative cosolutes (298 K, 20 mM KH2PO4/K2HPO4, pH 
7.4). (A) Fraction dimer is calculated from the area of monomer (M) and dimer (D) resonances shown 
panel B at five GB1-A34TFMF concentrations. Error bars indicate the standard deviation from three 
independent protein preparations. (B) 19F spectra of 125 µM GB1-A34TFMF in buffer (20 mM 
KH2PO4/K2HPO4, pH 7.4) and buffer plus 400 mM cosolute.  
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Figure S6 19F NMR spectra of GB1-A34TFMF at various pH values 
19F NMR spectra at 298 K of 125 µM GB1-A34TFMF in 50 mM HEPES, 50 mM citrate, 50 mM bis-tris 
propane at various pH values. Spectra are aligned by dimer resonance. Right hand scale indicates 
net charge of GB1-A34TFMF at each pH value. M = monomer; D = dimer; A = aggregate. 
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Figure S7 DLS characterization of GB1 aggregate at pH 4.0. 
Dynamic light scattering characterization of GB1-A34TFMF aggregate in 50 mM HEPES, 50 mM 
citrate, 50 mM bis-tris propane buffer, pH 4.0. Vertical line visualizes increase in radius (nm) after 
addition of trehalose. 
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Figure S8 NaCl induced changes in fraction dimer  
125 µM GB1-A34TFMF at 298 K in 20 mM KH2PO4/K2HPO4, pH 7.4 with increasing concentration of 
sodium chloride. 
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Figure S9 Cosolute induced changes in GB1 oligomerization at pH 4.0 
Cosolute (400 mM) induced changes in oligomerization of 50 µM GB1-A34TFMF in 50 mM HEPES, 
50 mM citrate, 50 mM bis-tris propane buffer, pH 4.0. (A) The effect of cosolutes on the fraction dimer 
+ aggregate. Error bars represent the standard deviation from three independent protein 
preparations. A horizontal line is drawn to visualize deviations from buffer. (B) The 19F spectra 
indicate three species at 50 μM. Resonances at -61.7 ppm and -62.0 ppm were assigned as the 
dimer and monomer, respectively, by dilution and monitoring the chemical shift versus pH. The third 
peak at -61.3 ppm is a higher order aggregate characterized by dynamic light scattering experiments, 
Figure S7. Addition of stabilizing cosolute, particularly trehalose promotes formation of aggregate. M 
= monomer; D = dimer; A = aggregate. 
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